Motor assembly for catheter pump

Information

  • Patent Grant
  • 11925797
  • Patent Number
    11,925,797
  • Date Filed
    Monday, November 30, 2020
    3 years ago
  • Date Issued
    Tuesday, March 12, 2024
    8 months ago
  • CPC
  • Field of Search
    • CPC
    • A61M60/00-90
  • International Classifications
    • A61M60/419
    • A61M60/13
    • A61M60/148
    • A61M60/216
    • A61M60/414
    • A61M60/422
    • A61M60/515
    • A61M60/538
    • Term Extension
      675
Abstract
A catheter pump is disclosed herein. The catheter pump can include a catheter assembly that comprises a drive shaft and an impeller coupled to a distal end of the drive shaft. A driven assembly can be coupled to a proximal end of the drive shaft within a driven assembly housing. The catheter pump can also include a drive system that comprises a motor and a drive magnet coupled to an output shaft of the motor. The drive system can include a drive assembly housing having at least one magnet therein. Further, a securement device can be configured to prevent disengagement of the driven assembly housing from the drive assembly housing during operation of the pump.
Description
BACKGROUND OF THE INVENTION
Field of the Invention

This application is directed to catheter pumps for mechanical circulatory support of a heart.


Description of the Related Art

Heart disease is a major health problem that has high mortality rate. Physicians increasingly use mechanical circulatory support systems for treating heart failure. The treatment of acute heart failure requires a device that can provide support to the patient quickly. Physicians desire treatment options that can be deployed quickly and minimally-invasively.


Intra-aortic balloon pumps (IABP) are currently the most common type of circulatory support devices for treating acute heart failure. IABPs are commonly used to treat heart failure, such as to stabilize a patient after cardiogenic shock, during treatment of acute myocardial infarction (MI) or decompensated heart failure, or to support a patient during high risk percutaneous coronary intervention (PCI). Circulatory support systems may be used alone or with pharmacological treatment.


In a conventional approach, an IABP is positioned in the aorta and actuated in a counterpulsation fashion to provide partial support to the circulatory system. More recently minimally-invasive rotary blood pump have been developed in an attempt to increase the level of potential support (i.e., higher flow). A rotary blood pump is typically inserted into the body and connected to the cardiovascular system, for example, to the left ventricle and the ascending aorta to assist the pumping function of the heart. Other known applications pumping venous blood from the right ventricle to the pulmonary artery for support of the right side of the heart. An aim of acute circulatory support devices is to reduce the load on the heart muscle for a period of time, to stabilize the patient prior to heart transplant or for continuing support.


There is a need for improved mechanical circulatory support devices for treating acute heart failure. Fixed cross-section ventricular assist devices designed to provide near full heart flow rate are either too large to be advanced percutaneously (e.g., through the femoral artery without a cutdown) or provide insufficient flow.


There is a need for a pump with improved performance and clinical outcomes. There is a need for a pump that can provide elevated flow rates with reduced risk of hemolysis and thrombosis. There is a need for a pump that can be inserted minimally-invasively and provide sufficient flow rates for various indications while reducing the risk of major adverse events. In one aspect, there is a need for a heart pump that can be placed minimally-invasively, for example, through a 15 FR or 12 FR incision. In one aspect, there is a need for a heart pump that can provide an average flow rate of 4 Lpm or more during operation, for example, at 62 mmHg of head pressure. While the flow rate of a rotary pump can be increased by rotating the impeller faster, higher rotational speeds are known to increase the risk of hemolysis, which can lead to adverse outcomes and in some cases death. Accordingly, in one aspect, there is a need for a pump that can provide sufficient flow at significantly reduced rotational speeds. These and other problems are overcome by the inventions described herein.


Further, there is a need for a motor configured to drive an operative device, e.g., a impeller, at a distal portion of the pump. It can be important for the motor to be configured to allow for percutaneous insertion of the pump's operative device.


SUMMARY OF THE INVENTION

There is an urgent need for a pumping device that can be inserted percutaneously and also provide full cardiac rate flows of the left, right, or both the left and right sides of the heart when called for.


In one embodiment, a catheter pump is disclosed. The catheter pump can include a catheter assembly. The catheter assembly can include a drive shaft having a proximal end and a distal end. An impeller may be coupled with the distal end of the drive shaft. A driven magnet assembly may be coupled with the proximal end of the drive shaft. The driven magnet assembly can include a driven magnet housing having a driven magnet. The catheter pump can further include a drive system. The drive system can include a motor having an output shaft. The drive system can also include a drive magnet assembly coupled with the output shaft. The drive magnet assembly can include a drive magnet housing with a drive magnet disposed therein. A securement device can be configured to secure the driven magnet housing into engagement with the drive magnet housing during operation of the pump.


In another embodiment, a catheter pump is disclosed. The catheter pump can include a catheter assembly. The catheter assembly can comprise a drive shaft having a proximal end and a distal end. An impeller can be coupled with the distal end of the drive shaft. A rotatable magnet can be coupled with the proximal end. The rotatable magnet can be disposed in a driven magnet housing. Furthermore, the catheter pump can include a drive system comprising a plurality of motor windings configured to induce rotation of the rotatable magnet when the driven magnet housing is engaged with the drive system. A locking device can be configured to be engaged by insertion of the driven magnet housing into an opening of the drive system.


In yet another embodiment, a method is disclosed. The method can include inserting a proximal portion of a catheter assembly containing a magnet into a recess of a drive unit. The method can further include engaging a locking device to secure the proximal portion of the catheter assembly to the drive unit.


In another embodiment, a catheter assembly is disclosed. The catheter assembly can include a catheter body having a proximal portion and a distal portion. An operative device can be coupled to the distal portion of the catheter body. A tip member can be coupled to a distal portion of the operative device. The tip member can have a lumen comprising a first section and a second section connected to the first section. An inner diameter of the first section can be larger than an inner diameter of the second section.


In one embodiment, a catheter pump is provided that includes a catheter assembly and a drive system, and a securement device. The catheter assembly includes a drive shaft, an impeller, and a driven assembly. The drive shaft has a proximal end and a distal end. The impeller is coupled with the distal end of the drive shaft. The driven assembly may be coupled with the proximal end of the drive shaft, the driven assembly is disposed in a driven housing. The drive system includes a motor having an output shaft and a drive assembly coupled with the output shaft. The drive assembly includes a drive housing with at least one magnet disposed therein. The securement device is configured to prevent disengagement of the driven housing from the drive housing during operation of the pump.


In one embodiment, a catheter pump is provided that includes a catheter assembly and a drive system, and a damper. The catheter assembly includes a drive shaft, an impeller, and a driven member. The drive shaft has a proximal end and a distal end. The impeller is coupled with the distal end of the drive shaft. The driven member is coupled with the proximal end of the drive shaft. The drive system includes a motor having an output shaft and a drive member coupled with the output shaft.


In one variant, the catheter pump can have a damper disposed between the drive and driven member. The damper can be configured to isolate the drive member or the motor from vibration in the catheter assembly. The damper can be configured to suppress noise at or around the connection between the drive and drive members.


Preferably, the damper is disposed radially around the output shaft, e.g., completely surrounding the output shaft. The damper can be disposed between separable housings of the catheter assembly and drive system, e.g., abutting a distal face of a drive system housing and a proximal face of a driven member housing disposed on the proximal end of the catheter assembly.


This embodiment can be augmented in some embodiments with a disconnectable coupling between the drive and driven members. For example, a securement device can be configured to permit selective disengagement of these components from each other. The securement device can be configured to prevent disengagement of the driven housing from the drive housing during operation of the pump.


Connection of the drive and driven members can be by the mutual attraction of opposing poles of permanent magnets disposed therein. Alternatively, the driven member can be positioned to be acted upon magnetic fields generated in the winding, e.g., using commutation in the windings. In another embodiment, the drive and driven members are coupled using direct mechanical drive, such as with gears, splines or other abutting surfaces.


In another embodiment, a catheter pump is provided that has a catheter assembly, a drive system, and a locking device. The catheter assembly has a drive shaft that has a proximal end and a distal end. An impeller is coupled with the distal end of the drive shaft. A rotatable magnet is coupled with the proximal end of the drive shaft. The rotatable magnet is disposed in a driven magnet housing. The drive system has a plurality of motor windings configured to induce rotation of the rotatable magnet after the driven magnet housing is engaged with the drive system. The locking device is configured to be engaged by insertion of the driven magnet housing into a portion or recess of the drive system.


Rotation can be induced in the rotatable magnet by the mutual attraction of opposing poles of permanent magnets. The rotatable magnet can be an assembly having one or a first plurality of permanent magnets and one or a second plurality of permanent magnets can be mounted on a shaft of the motor having the motor windings. Pairing of opposite poles of two magnets or of the magnets of the first and second pluralities of permanent magnets can induce rotation that can be transferred to the drive shaft. Alternatively, the rotatable magnet can be positioned to be acted upon magnetic fields generated in the winding, e.g., using commutation in the windings.


In another embodiment, a method is provided. A proximal portion of a catheter assembly containing a magnet is inserted into a recess of a drive unit. A locking device is engaged to secure the proximal portion of the catheter assembly to a distal portion of the drive unit.





BRIEF DESCRIPTION OF THE DRAWINGS

A more complete appreciation of the subject matter of this application and the various advantages thereof can be realized by reference to the following detailed description, in which reference is made to the accompanying drawings in which:



FIG. 1 illustrates one embodiment of a catheter pump configured for percutaneous application and operation;



FIG. 2 is a plan view of one embodiment of a catheter adapted to be used with the catheter pump of FIG. 1;



FIG. 3 show a distal portion of the catheter system similar to that of FIG. 2 in position within the anatomy;



FIG. 4 is a schematic view of a catheter assembly and a drive assembly;



FIG. 4A is an enlarged view of a priming apparatus shown in FIG. 4;



FIG. 5 is a three dimensional (3D) perspective view of a motor assembly as the drive assembly is being coupled to a driven assembly;



FIG. 6 is a 3D perspective view of the motor assembly once the drive assembly has been coupled and secured to the driven assembly;



FIG. 7 is a 3D perspective view of the motor assembly of FIG. 6, wherein various components have been removed for ease of illustration;



FIG. 8 is a plan view of the motor assembly that illustrates a motor, a drive magnet and a driven magnet;



FIG. 9 is a 3D perspective view of a first securement device configured to secure the drive assembly to the driven assembly;



FIGS. 10A-10C are 3D perspective views of a second securement device configured to secure the drive assembly to the driven assembly;



FIG. 11 illustrates a side schematic view of a motor assembly according to another embodiment;



FIGS. 12A-12B illustrates side schematic views of a motor assembly according to yet another embodiment;



FIG. 13 is a side view of a distal tip member disposed at a distal end of the catheter assembly, according to one embodiment;



FIG. 14 is a side cross-sectional view of a distal tip member disposed at a distal end of the catheter assembly, according to another embodiment.





More detailed descriptions of various embodiments of components for heart pumps useful to treat patients experiencing cardiac stress, including acute heart failure, are set forth below.


DETAILED DESCRIPTION

This application is directed to apparatuses for inducing motion of a fluid relative to the apparatus. For example, an operative device, such as an impeller, can be coupled at a distal portion of the apparatus. In particular, the disclosed embodiments generally relate to various configurations for a motor adapted to drive an impeller at a distal end of a catheter pump, e.g., a percutaneous heart pump. The disclosed motor assembly may be disposed outside the patient in some embodiments. In other embodiments, the disclosed motor assembly can be miniaturized and sized to be inserted within the body. FIGS. 1-3 show aspects of a catheter pump 10 that can provide high performance flow rates. The pump 10 includes a motor driven by a controller 22. The controller 22 directs the operation of the motor 14 and an infusion system 26 that supplies a flow of infusate in the pump 10. A catheter system 80 that can be coupled with the motor 14 houses an impeller within a distal portion thereof. In various embodiments, the impeller is rotated remotely by the motor 14 when the pump 10 is operating. For example, the motor 14 can be disposed outside the patient. In some embodiments, the motor 14 is separate from the controller 22, e.g., to be placed closer to the patient. In other embodiments, the motor 14 is part of the controller 22. In still other embodiments, the motor is miniaturized to be insertable into the patient. Such embodiments allow the drive shaft to be much shorter, e.g., shorter than the distance from the aortic valve to the aortic arch (about 5 cm or less). Some examples of miniaturized motors catheter pumps and related components and methods are discussed in U.S. Pat. Nos. 5,964,694; 6,007,478; 6,178,922; and 6,176,848, all of which are hereby incorporated by reference herein in their entirety for all purposes. Various embodiments of a motor are disclosed herein, including embodiments having separate drive and driven assemblies to enable the use of a guidewire guide passing through the catheter pump. As explained herein, a guidewire guide can facilitate passing a guidewire through the catheter pump for percutaneous delivery of the pump's operative device to a patient's heart.



FIG. 3 illustrates one use of the catheter pump 10. A distal portion of the pump 10, which can include an impeller assembly 92, is placed in the left ventricle LV of the heart to pump blood from the LV into the aorta. The pump 10 can be used in this way to treat patients with a wide range of conditions, including cardiogenic shock, myocardial infarction, and other cardiac conditions, and also to support a patient during a procedure such as percutaneous coronary intervention. One convenient manner of placement of the distal portion of the pump 10 in the heart is by percutaneous access and delivery using the Seldinger technique or other methods familiar to cardiologists. These approaches enable the pump 10 to be used in emergency medicine, a catheter lab and in other non-surgical settings. Modifications can also enable the pump 10 to support the right side of the heart. Example modifications that could be used for right side support include providing delivery features and/or shaping a distal portion that is to be placed through at least one heart valve from the venous side, such as is discussed in U.S. Pat. Nos. 6,544,216; 7,070,555; and US 2012-0203056A1, all of which are hereby incorporated by reference herein in their entirety for all purposes.



FIG. 2 shows features that facilitate small blood vessel percutaneous delivery and high performance, including up to and in some cases exceeding normal cardiac output in all phases of the cardiac cycle. In particular, the catheter system 80 includes a catheter body 84 and a sheath assembly 88. The impeller assembly 92 is coupled with the distal end of the catheter body 84. The impeller assembly 92 is expandable and collapsible. In the collapsed state, the distal end of the catheter system 80 can be advanced to the heart, for example, through an artery. In the expanded state the impeller assembly 92 is able to pump blood at high flow rates. FIGS. 2 and 3 illustrate the expanded state. The collapsed state can be provided by advancing a distal end 94 of an elongate body 96 distally over the impeller assembly 92 to cause the impeller assembly 92 to collapse. This provides an outer profile throughout the catheter assembly 80 that is of small diameter, for example, to a catheter size of about 12.5 FR in various arrangements.


In some embodiments, the impeller assembly 92 includes a self-expanding material that facilitates expansion. The catheter body 84 on the other hand preferably is a polymeric body that has high flexibility. When the impeller assembly 92 is collapsed, as discussed above, high forces are applied to the impeller assembly 92. These forces are concentrated at a connection zone, where the impeller assembly 92 and the catheter body 84 are coupled together. These high forces, if not carefully managed can result in damage to the catheter assembly 80 and in some cases render the impeller within the impeller assembly 92 inoperable. Robust mechanical interface, are provided to assure high performance.


The mechanical components rotatably supporting the impeller within the impeller assembly 92 permit high rotational speeds while controlling heat and particle generation that can come with high speeds. The infusion system 26 delivers a cooling and lubricating solution to the distal portion of the catheter system 80 for these purposes. However, the space for delivery of this fluid is extremely limited. Some of the space is also used for return of the infusate. Providing secure connection and reliable routing of infusate into and out of the catheter assembly 80 is critical and challenging in view of the small profile of the catheter body 84.


When activated, the catheter pump system can effectively increase the flow of blood out of the heart and through the patient's vascular system. In various embodiments disclosed herein, the pump can be configured to produce a maximum flow rate (e.g. low mm Hg) of greater than 4 Lpm, greater than 4.5 Lpm, greater than 5 Lpm, greater than 5.5 Lpm, greater than 6 Lpm, greater than 6.5 Lpm, greater than 7 Lpm, greater than 7.5 Lpm, greater than 8 Lpm, greater than 9 Lpm, or greater than 10 Lpm. In various embodiments, the pump can be configured to produce an average flow rate at 62 mmHg of greater than 2 Lpm, greater than 2.5 Lpm, greater than 3 Lpm, greater than 3.5 Lpm, greater than 4 Lpm, greater than 4.25 Lpm, greater than 4.5 Lpm, greater than 5 Lpm, greater than 5.5 Lpm, or greater than 6 Lpm.


Various aspects of the pump and associated components are similar to those disclosed in U.S. Pat. Nos. 7,393,181; 8,376,707; 7,841,976; 7,022,100; and 7,998,054, and in U.S. Pub. Nos. 2011/0004046; 2012/0178986; 2012/0172655; 2012/0178985; and 2012/0004495, the entire contents of each of which are incorporated herein for all purposes by reference. In addition, this application incorporates by reference in its entirety and for all purposes the subject matter disclosed in each of the following concurrently filed applications: application Ser. No. 13/802,556, which corresponds to, “DISTAL BEARING SUPPORT,” filed on the same date as this application; Application No. 61/780,656, which corresponds to, “FLUID HANDLING SYSTEM,” filed on the same date as this application; application Ser. No. 13/801,833, which corresponds to, “SHEATH SYSTEM FOR CATHETER PUMP,” filed on the same date as this application; application Ser. No. 13/802,570, which corresponds to, “IMPELLER FOR CATHETER PUMP,” filed on the same date as this application; and application Ser. No. 13/801,528, which corresponds to, “CATHETER PUMP,” filed on the same date as this application.


Another example of a catheter assembly 100A is illustrated in FIG. 4. Embodiments of the catheter pump of this application can be configured with a motor that is capable of coupling to (and in some arrangements optionally decoupling from) the catheter assembly 100A. This arrangement provides a number of advantages over a non-disconnectable housing. For example, access can be provided to a proximal end of the catheter assembly 100A prior to or during use. In one configuration, a catheter pump is delivered over a guidewire. The guidewire may be conveniently extended through the entire length of the catheter assembly 100A and out of a proximal portion thereof that is completely enclosed in a coupled configuration. For this approach, connection of the proximal portion of the catheter assembly 100A to a motor housing can be completed after a guidewire has been used to guide the operative device of the catheter pump to a desired location within the patient, e.g., to a chamber of the patient's heart. In one embodiment, the connection between the motor housing and the catheter assembly is configured to be permanent, such that the catheter assembly, the motor housing and the motor are disposable components. However, in other implementations, the coupling between the motor housing and the catheter assembly is disengageable, such that the motor and motor housing can be decoupled from the catheter assembly after use. In such embodiments, the catheter assembly distal of the motor can be disposable, and the motor and motor housing can be re-usable.


Moving from the distal end of the catheter assembly 100A of FIG. 4 to the proximal end, a priming apparatus 1400 can be disposed over an impeller assembly 116A. As explained above, the impeller assembly 116A can include an expandable cannula or housing and an impeller with one or more blades. As the impeller rotates, blood can be pumped proximally (or distally in some implementations) to function as a cardiac assist device.



FIG. 4 also shows one example of a priming apparatus 1400 disposed over the impeller assembly 116A near the distal end 170A of the elongate body 174A. FIG. 4A is an enlarged view of the priming apparatus 1400 shown in FIG. 4. The priming apparatus 1400 can be used in connection with a procedure to expel air from the impeller assembly 116A, e.g., any air that is trapped within the housing or that remains within the elongate body 174A near the distal end 170A. For example, the priming procedure may be performed before the pump is inserted into the patient's vascular system, so that air bubbles are not allowed to enter and/or injure the patient. The priming apparatus 1400 can include a primer housing 1401 configured to be disposed around both the elongate body 174A and the impeller assembly 116A. A sealing cap 1406 can be applied to the proximal end 1402 of the primer housing 1401 to substantially seal the priming apparatus 1400 for priming, i.e., so that air does not proximally enter the elongate body 174A and also so that priming fluid does not flow out of the proximal end of the housing 1401. The sealing cap 1406 can couple to the primer housing 1401 in any way known to a skilled artisan. However, in some embodiments, the sealing cap 1406 is threaded onto the primer housing by way of a threaded connector 1405 located at the proximal end 1402 of the primer housing 1401. The sealing cap 1406 can include a sealing recess disposed at the distal end of the sealing cap 1406. The sealing recess can be configured to allow the elongate body 174A to pass through the sealing cap 1406.


The priming operation can proceed by introducing fluid into the sealed priming apparatus 1400 to expel air from the impeller assembly 116A and the elongate body 174A. Fluid can be introduced into the priming apparatus 1400 in a variety of ways. For example, fluid can be introduced distally through the elongate body 174A into the priming apparatus 1400. In other embodiments, an inlet, such as a luer, can optionally be formed on a side of the primer housing 1401 to allow for introduction of fluid into the priming apparatus 1400.


A gas permeable membrane can be disposed on a distal end 1404 of the primer housing 1401. The gas permeable membrane can permit air to escape from the primer housing 1401 during priming.


The priming apparatus 1400 also can advantageously be configured to collapse an expandable portion of the catheter assembly 100A. The primer housing 1401 can include a funnel 1415 where the inner diameter of the housing decreases from distal to proximal. The funnel may be gently curved such that relative proximal movement of the impeller housing causes the impeller housing to be collapsed by the funnel 1415. During or after the impeller housing has been fully collapsed, the distal end 170A of the elongate body 174A can be moved distally relative to the collapsed housing. After the impeller housing is fully collapsed and retracted into the elongate body 174A of the sheath assembly, the catheter assembly 100A can be removed from the priming housing 1400 before a percutaneous heart procedure is performed, e.g., before the pump is activated to pump blood. The embodiments disclosed herein may be implemented such that the total time for infusing the system is minimized or reduced. For example, in some implementations, the time to fully infuse the system can be about six minutes or less. In other implementations, the time to infuse can be about three minutes or less. In yet other implementations, the total time to infuse the system can be about 45 seconds or less. It should be appreciated that lower times to infuse can be advantageous for use with cardiovascular patients.


With continued reference to FIG. 4, the elongate body 174A extends proximally from the impeller assembly 116A to an infusate device 195 configured to allow for infusate to enter the catheter assembly 100A and for waste fluid to leave the catheter assembly 100A. A catheter body 120A (which also passes through the elongate body 174A) can extend proximally and couple to a driven assembly 201. The driven assembly 201 can be configured to receive torque applied by a drive assembly 203, which is shown as being decoupled from the driven assembly 201 and the catheter assembly 100A in FIG. 4. Although not shown in FIG. 4, a drive shaft can extend from the driven assembly 201 through the catheter body 120A to couple to an impeller shaft at or proximal to the impeller assembly 116A. The catheter body 120A can pass within the elongate catheter body 174A such that the external catheter body 174A can axially translate relative to the catheter body 120A.


In addition, FIG. 4 illustrates a guidewire 235 extending from a proximal guidewire opening 237 in the driven assembly 201. Before inserting the catheter assembly 100A into a patient, a clinician may insert the guidewire 235 through the patient's vascular system to the heart to prepare a path for the operative device (e.g., the impeller assembly 116A) to the heart. In some embodiments, the catheter assembly can include a guidewire guide tube (see FIG. 12) passing through a central internal lumen of the catheter assembly 100A from the proximal guidewire opening 237. The guidewire guide tube can be pre-installed in the catheter assembly 100A to provide the clinician with a preformed pathway along which to insert the guidewire 235.


In one approach, a guidewire is first placed in a conventional way, e.g., through a needle into a peripheral blood vessel, and along the path between that blood vessel and the heart and into a heart chamber, e.g., into the left ventricle. Thereafter, a distal end opening of the catheter assembly or guidewire guide can be advanced over the proximal end of the guidewire 235 to enable delivery to the catheter assembly 100A. After the proximal end of the guidewire 235 is urged proximally within the catheter assembly 100A and emerges from the guidewire opening 237 and/or guidewire guide, the catheter assembly 100A can be advanced into the patient. In one method, the guidewire guide is withdrawn proximally while holding the catheter assembly 100A. The guidewire guide is taken off of the catheter assembly 100A so that guidewire lumens from the proximal end to the distal end of the catheter assembly 100A are directly over the guidewire.


Alternatively, the clinician can thus insert the guidewire 235 through the proximal guidewire opening 237 and urge the guidewire 235 along the guidewire guide tube until the guidewire 235 extends from a distal guidewire opening (not shown) in the distal end of the catheter assembly 100A. The clinician can continue urging the guidewire 235 through the patient's vascular system until the distal end of the guidewire 235 is positioned in the desired chamber of the patient's heart. As shown in FIG. 4, a proximal end portion of the guidewire 235 can extend from the proximal guidewire opening 237. Once the distal end of the guidewire 235 is positioned in the heart, the clinician can maneuver the impeller assembly 116A over the guidewire 235 until the impeller assembly 116A reaches the distal end of the guidewire 235 in the heart. The clinician can remove the guidewire 235 and the guidewire guide tube. The guidewire guide tube can also be removed before or after the guidewire 235 is removed in some implementations.


After removing at least the guidewire 235, the clinician can activate a motor to rotate the impeller and begin operation of the pump.


One problem that arises when using the guidewire 235 to guide the operative device to the heart is that a central lumen or tube (e.g., a guidewire guide) is typically formed to provide a path for the guidewire 235. In some implementations, it may be inconvenient or inoperable to provide a motor or drive assembly having a lumen through which the guidewire 235 can pass. Moreover, in some implementations, it may be desirable to provide the motor or drive assembly separate from the catheter assembly 100A, e.g., for manufacturing or economic purposes. Thus, it can be advantageous to provide a means to couple the drive assembly 203 to the driven assembly 201, while enabling the use of a guidewire guide through which a guidewire may be passed. Preferably, the drive assembly 203 can be securely coupled to the driven assembly 201 such that vibratory, axial, or other external forces do not decouple the drive assembly 203 from the driven assembly 201 during operation. Moreover, the coupling should preferably allow a motor to operate effectively so that the drive shaft is rotated at the desired speed and with the desired torque.



FIG. 5 illustrates one embodiment of a motor assembly 206 as the driven assembly 201 is being coupled to the drive assembly 203. The driven assembly 201 can include a flow diverter 205 and a flow diverter housing 207 that houses the flow diverter 205. The flow diverter 205 can be configured with a plurality of internal cavities, passages, and channels that are configured to route fluid to and from the patient during a medical procedure. As discussed below, an infusate can be directed into the flow diverter from a source of infusate. The infusate is a fluid that flows into the catheter body 120A to provide useful benefits, such as cooling moving parts and keeping blood from entering certain parts of the catheter assembly 100A. The infusate is diverted distally by flow channels in the flow diverter 205. Some of the infusate that flows distally is re-routed back through the catheter body 120A and may be diverted out of the catheter assembly 100A by the flow diverter 205. Moreover, a driven magnet 204 can be disposed within the flow diverter 205 in various embodiments. For example, the driven magnet 204 can be journaled for rotation in a proximal portion of the flow diverter housing 207. The proximal portion can project proximally of a proximal face of a distal portion of the flow diverter housing 207. In other embodiments, the driven magnet 204 can be disposed outside the flow diverter 205. The driven magnet 204 can be configured to rotate freely relative to the flow diverter 205 and/or the flow diverter housing 207. The catheter body 120A can extend from a distal end of the flow diverter housing 207. Further, a drive shaft 208 can pass through the catheter body 120A from the proximal end of the flow diverter housing 207 to the distal end 170A of the elongate body 174A. The drive shaft 208 can be configured to drive the impeller located at the distal end of the catheter assembly 100A. In some embodiments, a distal end of the drive shaft 208 can couple to an impeller shaft, which rotates the impeller.


The drive assembly 203 can include a drive housing or a motor housing 211 having an opening 202 in a cap 212 of the motor housing 211. The motor housing 211 can also have a sliding member 213, which can be configured to couple to the patient's body by way of, e.g., a connector 291 coupled to an adhesive or bandage on the patient's body. Because the motor and motor housing 211 can have a relatively high mass, it can be important to ensure that the motor housing 211 is stably supported. In one implementation, therefore, the motor housing 211 can be supported by the patient's body by way of the sliding member 213 and the connector 291 shown in FIG. 4. The sliding member 213 can slide along a track 214 located on a portion of the motor housing 211, such that relative motion between the motor assembly 206 and the patient does not decouple the sliding member 213 from the patient's body. The sliding member 213 and connector 291 can therefore be configured to provide a structural interface between the motor housing 206 and a platform for supporting the motor housing 211. As explained above, in some arrangements, the platform supporting the motor housing 211 can be the patient, since the motor housing 211 may be positioned quite close to the insertion point. In other arrangements, however, the platform supporting the motor housing 211 may be an external structure.


To couple the drive assembly 203 to the driven assembly 201, the clinician or user can insert the proximal portion of the flow diverter 205 into the opening 202 in the cap 212 of the motor housing 212. After passing through the opening 202, the proximal portion of the flow diverter can reside within a recess formed within the motor housing 211. In some implementations, a securement device is configured to lock or secure the drive assembly 203 to the driven assembly 201 once the driven assembly 201 is fully inserted into the drive assembly 203. In other implementations, the securement device can be configured to secure the drive assembly 203 to the driven assembly 201 by inserting the driven assembly 201 into the drive assembly 203 and then rotating the drive assembly 203 with respect to the driven assembly. In some implementations, coupling the drive assembly 203 to the driven assembly 201 may be irreversible, such that there may be no release mechanism to decouple the drive assembly 203 from the driven assembly 201. In implementations without a release mechanism, the catheter assembly 100A (including the driven assembly 201) and the motor housing 211 may be disposable components. In other implementations, however, a release mechanism may be provided to remove the drive assembly 203 from the driven assembly 201. The drive assembly 203 can thereby be used multiple times in some embodiments.



FIG. 6 illustrates the motor assembly 206 in the assembled state, e.g., after the drive assembly 203 has been secured to the driven assembly 201. When the drive assembly 203 is activated (e.g., a motor is activated to rotate an output shaft), the driven assembly 201, which is operably coupled to the drive assembly, is also activated. The activated driven assembly can cause the drive shaft 208 to rotate, which in turn causes the impeller to rotate to thereby pump blood through the patient.



FIGS. 7-8 illustrate the motor assembly 206 with one wall of the motor housing 211 removed so that various internal components in the housing 211 can be better illustrated. A motor 220 can be positioned within the housing 211 and mounted by way of a motor mount 226. The motor 220 can operably couple to a drive magnet 221. For example, the motor 220 can include an output shaft 222 that rotates the drive magnet 221. In some implementations, the drive magnet 221 can rotate relative to the motor mount 226 and the motor housing 211. Further, in some arrangements, the drive magnet 221 can be free to translate axially between the motor mount and a barrier 224. One advantage of the translating capability is to enable the drive magnet 221 and the driven magnet 204 to self-align by way of axial translation. The barrier 224 can be mounted to the motor housing 211 and at least partially within the cap 212 to support at least the drive magnet 221. In other implementations, the drive assembly 203 can comprise a plurality of motor windings configured to induce rotation of the drive magnet 221. In still other embodiments, motor windings can operate directly on a driven magnet within the driven assembly 201. For example, the windings can be activated in phases to create an electric field and thereby commutate the driven magnet.


In FIG. 8, the drive magnet 221 is illustrated in phantom, such that the driven magnet 204 can be seen disposed within the drive magnet 221. Although not illustrated, the poles of the drive magnet 221 can be formed on an interior surface of the drive magnet 221, and the poles of the driven magnet 204 can be formed on an exterior surface of the driven magnet 204. As the drive magnet 221 rotates, the poles of the drive magnet 221 can magnetically engage with corresponding, opposite poles of the driven magnet 204 to cause the driven magnet 204 to rotate with, or follow, the drive magnet 221. Because the driven magnet 204 can be mechanically coupled to the drive shaft 208, rotation of the drive magnet 221 can cause the driven magnet 204 and the drive shaft 208 to rotate at a speed determined in part by the speed of the motor 220. Furthermore, when the driven magnet 204 is inserted into the drive magnet 221, the poles of each magnet can cause the drive magnet 221 and the driven magnet 204 to self-align. The magnetic forces between the drive magnet 221 and the driven magnet 204 can assist in coupling the drive assembly 203 to the driven assembly 201.


Turning to FIG. 9, a 3D perspective view of various components at the interface between the drive assembly 203 and the driven assembly 201 is shown. Various components have been hidden to facilitate illustration of one means to secure the drive assembly 203 to the driven assembly 201. A first securement device 240 is illustrated in FIG. 9. The first securement device can comprise a first projection 240a and a second projection 240b. Furthermore, a locking recess 244 can be formed in the cap 212 around at least a portion of a perimeter of the opening 202. A lip 242 can also extend from the perimeter at least partially into the opening 202. As shown, the lip 242 can also extend proximally from the locking recess 244 such that a step is formed between the locking recess 244 and the lip 242. Further, a flange 246 can be coupled to or formed integrally with the flow diverter housing 207. The flange 246 can include a plurality of apertures 247a, 247b, 247c, 247d that are configured to permit tubes and cables to pass therethrough to fluidly communicate with lumens within the flow diverter 205. In some implementations, three tubes and one electrical cable can pass through the apertures 247a-d. For example, the electrical cable can be configured to electrically couple to a sensor within the catheter assembly 100A, e.g., a pressure sensor. The three tubes can be configured to carry fluid to and from the catheter assembly 100A. For example, a first tube can be configured to carry infusate into the catheter assembly 100A, a second tube can be configured to transport fluids to the pressure sensor region, and the third tube can be configured to transport waste fluid out of the catheter assembly 100A. Although not illustrated, the tubes and cable(s) can pass through the apertures 247a-d of the flange 246 and can rest against the motor housing 211. By organizing the routing of the tubes and cable(s), the apertures 247a-d can advantageously prevent the tubes and cable(s) from becoming entangled with one another or with other components of the catheter pump system.


When the driven assembly 201 is inserted into the opening 202, the first and second projections 240a, 240b can pass through the opening and engage the locking recess 244. In some implementations, the projections 240a, 240b and the locking recess 244 can be sized and shaped such that axial translation of the projections 240a, 240b through the opening 202 causes a flange or tab 248 at a distal end of each projection 240a, 240b to extend over the locking recess 244. Thus, in some embodiments, once the projections 240a, 240b are inserted through the opening 202, the tabs 248 at the distal end of the projections 240a, 240b are biased to deform radially outward to engage the locking recess 244 to secure the driven assembly 201 to the drive assembly 203.


Once the driven assembly 201 is secured to the drive assembly 203, the flow diverter housing 207 can be rotated relative to the motor cap 212. By permitting relative rotation between the driven assembly 201 and the drive assembly 203, the clinician is able to position the impeller assembly 116A within the patient at a desired angle or configuration to achieve the best pumping performance. As shown in FIG. 9, however, the lip 242 can act to restrict the relative rotation between the driven assembly 201 (e.g., the flow diverter housing 207) and the drive assembly 203 (e.g. the cap 212 and the motor housing 211). As illustrated, the flange 246 and apertures 247a-d can be circumferentially aligned with the projections 240a, 240b. Further, the lip 242 can be circumferentially aligned with the sliding member 213, the track 214, and the connector 291 of the motor housing 211. If the flange 246 and projections 240a, 240b are rotated such that they circumferentially align with the lip 242, then the tubes and cable(s) that extend from the apertures 247a-d may become entangled with or otherwise obstructed by the sliding member 213 and the connector 291. Thus, it can be advantageous to ensure that the sliding member 213 and the connector 291 (or any other components on the outer surface of the housing 211) do not interfere or obstruct the tubes and cable(s) extending out of the apertures 247a-d of the flange 246. The lip 242 formed in the cap 212 can act to solve this problem by ensuring that the flange 246 is circumferentially offset from the sliding member 213 and the connector 291. For example, the flow diverter housing 207 can be rotated until one of the projections 240a, 240b bears against a side of the lip 242. By preventing further rotation beyond the side of the lip 242, the lip 242 can ensure that the flange 246 and apertures 247a-d are circumferentially offset from the sliding member 213, the track 214, and the connector 291.


In one embodiment, once the catheter assembly 100A is secured to the motor housing 211, the connection between the driven assembly 201 and the drive assembly 203 may be configured such that the drive assembly 203 may not be removed from the driven assembly 201. The secure connection between the two assemblies can advantageously ensure that the motor housing 211 is not accidentally disengaged from the catheter assembly 100A during a medical procedure. In such embodiments, both the catheter assembly 100A and the drive assembly 203 may preferably be disposable.


In other embodiments, however, it may be desirable to utilize a re-usable drive assembly 203. In such embodiments, therefore, the drive assembly 203 may be removably engaged with the catheter assembly 100A (e.g., engaged with the driven assembly 201). For example, the lip 242 may be sized and shaped such that when the drive assembly 203 is rotated relative to the driven assembly 201, the tabs 248 are deflected radially inward over the lip 242 such that the driven assembly 201 can be withdrawn from the opening 202. For example, the lip 242 may include a ramped portion along the sides of the lip 242 to urge the projections 240a, 240b radially inward. It should be appreciated that other release mechanisms are possible.


Turning to FIGS. 10A-10C, an additional means to secure the drive assembly 203 to the driven assembly 201 is disclosed. As shown in the 3D perspective view of FIG. 10A, a locking O-ring 253 can be mounted to the barrier 224 that is disposed within the motor housing 211 and at least partially within the cap 212. In particular, the locking O-ring 253 can be mounted on an inner surface of the drive or motor housing 203 surrounding the recess or opening 202 into which the driven assembly 212 can be received As explained below, the locking O-ring can act as a detent mechanism and can be configured to be secured within an arcuate channel formed in an outer surface of the driven assembly 201, e.g., in an outer surface of the flow diverter 205 in some embodiments. In other embodiments, various other mechanisms can act as a detent to secure the driven assembly 201 to the drive assembly 203. For example, in one embodiment, a spring plunger or other type of spring-loaded feature may be cut or molded into the barrier 224, in a manner similar to the locking O-ring 253 of FIGS. 10A-10C. The spring plunger or spring-loaded feature can be configured to engage the arcuate channel, as explained below with respect to FIG. 10C. Skilled artisans will understand that other types of detent mechanisms can be employed.



FIG. 10B illustrates the same 3D perspective of the drive assembly 203 as shown in FIG. 10A, except the cap 212 has been hidden to better illustrate the locking O-ring 253 and a second, stabilizing O-ring 255. The O-ring 255 is an example of a damper that can be provided between the motor 220 and the catheter assembly 100A. The damper can provide a vibration absorbing benefit in some embodiments. In other embodiment, the damper may reduce noise when the pump is operating. The damper can also both absorb vibration and reduce noise in some embodiments. The stabilizing O-ring 255 can be disposed within the cap 212 and can be sized and shaped to fit along the inner recess forming the inner perimeter of the cap 212. The stabilizing O-ring 255 can be configured to stabilize the cap 212 and the motor housing 211 against vibrations induced by operation of the motor 220. For example, as the motor housing 211 and/or cap 212 vibrate, the stabilizing O-ring 255 can absorb the vibrations transmitted through the cap 212. The stabilizing O-ring 255 can support the cap 212 to prevent the cap from deforming or deflecting in response to vibrations. In some implementations, the O-ring 255 can act to dampen the vibrations, which can be significant given the high rotational speeds involved in the exemplary device.


In further embodiments, a damping material can also be applied around the motor 220 to further dampen vibrations. The damping material can be any suitable damping material, e.g., a visco-elastic or elastic polymer. For example, the damping material may be applied between the motor mount 226 and the motor 220 in some embodiments. In addition, the damping material may also be applied around the body of the motor 220 between the motor 220 and the motor housing 211. In some implementations, the damping material may be captured by a rib formed in the motor housing 211. The rib may be formed around the motor 220 in some embodiments.


Turning to FIG. 10C, a proximal end of the driven assembly 201 is shown. As explained above, the flow diverter 205 (or the flow diverter housing in some embodiments) can include an arcuate channel 263 formed in an outer surface of the flow diverter 205. The arcuate channel 263 can be sized and shaped to receive the locking O-ring 253 when the flow diverter 205 is inserted into the opening 202 of the drive assembly 203. As the flow diverter 205 is axially translated through the recess or opening 202, the locking O-ring 253 can be urged or slid over an edge of the channel 263 and can be retained in the arcuate channel 263. Thus, the locking O-ring 253 and the arcuate channel 263 can operate to act as a second securement device. Axial forces applied to the motor assembly 206 can thereby be mechanically resisted, as the walls of the arcuate channel 263 bear against the locking O-ring 253 to prevent the locking o-ring 253 from translating relative to the arcuate channel 263. In various arrangements, other internal locking mechanisms (e.g., within the driven assembly 201 and/or the drive assembly 203) can be provided to secure the driven and drive assemblies 201, 203 together. For example, the driven magnet 204 and the drive magnet 221 may be configured to assist in securing the two assemblies together, in addition to aligning the poles of the magnets. Other internal locking mechanisms may be suitable.



FIG. 10C also illustrates a resealable member 266 disposed within the proximal end portion of the driven assembly 201, e.g., the proximal end of the catheter assembly 100A as shown in FIG. 4. As in FIG. 4, the proximal guidewire opening 237 can be formed in the resealable member 266. As explained above with respect to FIG. 4, the guidewire 235 can be inserted through the proximal guidewire opening 237 and can be maneuvered through the patient's vasculature. After guiding the operative device of the pump to the heart, the guidewire 235 can be removed from the catheter assembly 100A by pulling the guidewire 235 out through the proximal guidewire opening 237. Because fluid may be introduced into the flow diverter 205, it can be advantageous to seal the proximal end of the flow diverter 205 to prevent fluid from leaking out of the catheter assembly 100A. The resealable member 266 can therefore be formed of an elastic, self-sealing material that is capable of closing and sealing the proximal guidewire opening 237 when the guidewire 235 is removed. The resealable member can be formed of any suitable material, such as an elastomeric material. In some implementations, the resealable member 266 can be formed of any suitable polymer, e.g., a silicone or polyisoprene polymer. Skilled artisans will understand that other suitable materials may be used.



FIG. 11 illustrates yet another embodiment of a motor assembly 206A coupled to a catheter assembly. In FIG. 11, a flow diverter is disposed over and coupled to a catheter body 271 that can include a multi-lumen sheath configured to transport fluids into and away from the catheter assembly. The flow diverter 205A can provide support to the catheter body 271 and a drive shaft configured to drive the impeller assembly. Further, the motor assembly 206A can include a motor 220A that has a hollow lumen therethrough. Unlike the embodiments disclosed in FIGS. 4-10C, the guidewire 235 may extend through the proximal guidewire opening 237A formed proximal to the motor 220A, rather than between the motor 220A and the flow diverter 205A. A resealable member 266A may be formed in the proximal guidewire opening 237A such that the resealable member 266A can close the opening 237A when the guidewire 235 is removed from the catheter assembly. A rotary seal 273 may be disposed inside a lip of the flow diverter 205A. The rotary seal 273 may be disposed over and may contact a motor shaft extending from the motor 220A. The rotary seal 273 can act to seal fluid within the flow diverter 205A. In some embodiments, a hydrodynamic seal can be created to prevent fluid from breaching the rotary seal 273.


In the implementation of FIG. 11, the motor 220A can be permanently secured to the flow diverter 205A and catheter assembly. Because the proximal guidewire opening 237 is positioned proximal the motor, the motor 220A need not be coupled with the catheter assembly in a separate coupling step. The motor 220A and the catheter assembly can thus be disposable in this embodiment. The motor 220A can include an output shaft and rotor magnetically coupled with a rotatable magnet in the flow diverter 205A. The motor 220A can also include a plurality of windings that are energized to directly drive the rotatable magnet in the flow diverter 205A.



FIGS. 12A-12B illustrate another embodiment of a motor coupling having a driven assembly 401 and a drive assembly 403. Unlike the implementations disclosed in FIGS. 4-10C, however, the embodiment of FIGS. 12A-12B can include a mechanical coupling disposed between an output shaft of a motor and a proximal end of a flexible drive shaft or cable. Unlike the implementations disclosed in FIG. 11, however, the embodiment of FIGS. 12A-12B can include a guidewire guide tube that terminates at a location distal to a motor shaft 476 that extends from a motor 420. As best shown in FIG. 12B, an adapter shaft 472 can operably couple to the motor shaft 476 extending from the motor 420. A distal end portion 477 of the adapter shaft 472 can mechanically couple to a proximal portion of an extension shaft 471 having a central lumen 478 therethrough. As shown in FIG. 12B, one or more trajectories 473 can be formed in channels within a motor housing 475 at an angle to the central lumen 478 of the extension shaft 471. The motor housing 475 can enclose at least the adapter shaft 472 and can include one or more slots 474 formed through a wall of the housing 475.


In some implementations, a guidewire (not shown in FIG. 12B) may pass through the guidewire guide tube from the distal end portion of the catheter assembly and may exit the assembly through the central lumen 478 near the distal end portion 477 of the adapter shaft 472 (or, alternatively, near the proximal end portion of the extension shaft 471). In some embodiments, one of the extension shaft 471 and the adapter shaft 472 may include a resealable member disposed therein to reseal the lumen through which the guidewire passes, as explained above. In some embodiments, the extension shaft 471 and the adapter shaft 472 can be combined into a single structure. When the guidewire exits the central lumen 478, the guidewire can pass along the angled trajectories 473 which can be formed in channels and can further pass through the slots 474 to the outside environs. The trajectories 473 can follow from angled ports in the adapter shaft 472. A clinician can thereby pull the guidewire through the slots 474 such that the end of the guidewire can easily be pulled from the patient after guiding the catheter assembly to the heart chamber or other desired location. Because the guidewire may extend out the side of the housing 475 through the slots, the motor shaft 476 and motor 420 need not include a central lumen for housing the guidewire. Rather, the motor shaft 476 may be solid and the guidewire can simply pass through the slots 474 formed in the side of the housing 475.


Furthermore, the drive assembly 403 can mechanically couple to the driven assembly 401. For example, a distal end portion 479 of the extension shaft 471 may be inserted into an opening in a flow diverter housing 455. The distal end portion 479 of the extension shaft 471 may be positioned within a recess 451 and may couple to a proximal end of a drive cable 450 that is mechanically coupled to the impeller assembly. A rotary seal 461 may be positioned around the opening and can be configured to seal the motor 420 and/or motor housing 475 from fluid within the flow diverter 405. Advantageously, the embodiments of FIGS. 12A-B allow the motor 420 to be positioned proximal of the rotary seal in order to minimize or prevent exposing the motor 420 to fluid that may inadvertently leak from the flow diverter. It should be appreciated that the extension shaft 471 may be lengthened in order to further isolate or separate the motor 420 from the fluid diverter 405 in order to minimize the risk of leaking fluids.


Turning to FIG. 13, further features that may be included in various embodiments are disclosed. FIG. 13 illustrates a distal end portion 300 of a catheter assembly, such as the catheter assembly 100A described above. As shown a cannula housing 302 can couple to a distal tip member 304. The distal tip member 304 can be configured to assist in guiding the operative device of the catheter assembly, e.g., an impeller assembly (which can be similar to or the same as impeller assembly 116A), along the guidewire 235. The exemplary distal tip member 304 is formed of a flexible material and has a rounded end to prevent injury to the surrounding tissue. If the distal tip member 304 contacts a portion of the patient's anatomy (such as a heart wall or an arterial wall), the distal tip member 304 will safely deform or bend without harming the patient. The tip can also serve to space the operative device away from the tissue wall. In addition, a guidewire guide tube 312, discussed above with reference to FIG. 4, can extend through a central lumen of the catheter assembly. Thus, the guidewire guide tube 312 can pass through the impeller shaft (not shown, as the impeller is located proximal to the distal end portion 300 shown in FIG. 13) and a lumen formed within the distal tip member 304. In the embodiment of FIG. 13, the guidewire guide tube 312 may extend distally past the distal end of the distal tip member 304. As explained above, in various embodiments, the clinician can introduce a proximal end of the guidewire into the distal end of the guidewire guide tube 312, which in FIG. 13 extends distally beyond the tip member 304. Once the guidewire 235 has been inserted into the patient, the guidewire guide tube 312 can be removed from the catheter assembly in some implementations.


The distal tip member 304 can comprise a flexible, central body 306, a proximal coupling member 308, and a rounded tip 310 at the distal end of the tip member 304. The central body 306 can provide structural support for the distal tip member 304. The proximal coupling member 308 can be coupled to or integrally formed with the central body 306. The proximal coupling member 308 can be configured to couple the distal end of the cannula housing 302 to the distal tip member 304. The rounded tip 310, also referred to as a ball tip, can be integrally formed with the central body 306 at a distal end of the tip member 304. Because the rounded tip 310 is flexible and has a round shape, if the tip member 304 contacts or interacts with the patient's anatomy, the rounded tip 310 can have sufficient compliance so as to deflect away from the anatomy instead of puncturing or otherwise injuring the anatomy. As compared with other potential implementations, the distal tip member 304 can advantageously include sufficient structure by way of the central body 306 such that the tip member 304 can accurately track the guidewire 235 to position the impeller assembly within the heart. Yet, because the tip member 304 is made of a flexible material and includes the rounded tip 310, any mechanical interactions with the anatomy can be clinically safe for the patient.


One potential problem with the embodiment of FIG. 13 is that it can be difficult for the clinician to insert the guidewire into the narrow lumen of the guidewire guide tube 312. Since the guidewire guide tube 312 has a small inner diameter relative to the size of the clinician's hands, the clinician may have trouble inserting the guidewire into the distal end of the guidewire guide tube 312, which extends past the distal end of the tip member 304 in FIG. 13. In addition, when the clinician inserts the guidewire into the guidewire guide tube 312, the distal edges of the guidewire guide tube 312 may scratch or partially remove a protective coating applied on the exterior surface of the guidewire. Damage to the coating on the guidewire may harm the patient as the partially uncoated guidewire is passed through the patient's vasculature. Accordingly, it can be desirable in various arrangements to make it easier for the clinician to insert the guidewire into the distal end of the catheter assembly, and/or to permit insertion of the guidewire into the catheter assembly while maintaining the protective coating on the guidewire.


Additionally, as explained herein, the cannula housing 302 (which may form part of an operative device) may be collapsed into a stored configuration in some embodiments such that the cannula housing is disposed within an outer sheath. When the cannula housing 302 is disposed within the outer sheath, a distal end or edge of the outer sheath may abut the tip member 304. In some cases, the distal edge of the outer sheath may extend over the tip member 304A, or the sheath may have an outer diameter such that the distal edge of the outer sheath is exposed. When the sheath is advanced through the patient's vasculature, the distal edge of the outer sheath may scratch, scrape, or otherwise harm the anatomy. There is a therefore a need to prevent harm to the patient's anatomy due to scraping of the distal edge of the sheath against the vasculature.



FIG. 14 is a side cross-sectional view of a distal tip member 304A disposed at a distal end 300A of the catheter assembly, according to another embodiment. Unless otherwise noted, the reference numerals in FIG. 14 may refer to components similar to or the same as those in FIG. 13. For example, as with FIG. 13, the distal tip member 304A can couple to a cannula housing 302A. The distal tip member 304A can include a flexible, central body 306A, a proximal coupling member 308A, and a rounded tip 310A at the distal end of the tip member 304A. Furthermore, as with FIG. 13, a guidewire guide tube 312A can pass through the cannula housing 302A and a lumen passing through the distal tip member 304A.


However, unlike the embodiment of FIG. 13, the central body 306A can include a bump 314 disposed near a proximal portion of the tip member 304A. The bump 314 illustrated in FIG. 14 may advantageously prevent the outer sheath from scraping or scratching the anatomy when the sheath is advanced through the patient's vascular system. For example, when the cannula housing 302A is disposed within the outer sheath, the sheath will advance over the cannula housing 302A such that the distal edge or end of the sheath will abut or be adjacent the bump 314 of the tip member 304A. The bump 314 can act to shield the patient's anatomy from sharp edges of the outer sheath as the distal end 300A is advanced through the patient. Further, the patient may not be harmed when the bump 314 interact with the anatomy, because the bump 314 includes a rounded, smooth profile. Accordingly, the bump 314 in FIG. 14 may advantageously improve patient outcomes by further protecting the patient's anatomy.


Furthermore, the guidewire guide tube 312A of FIG. 14 does not extend distally past the end of the tip member 306A. Rather, in FIG. 14, the central lumen passing through the tip member 304A may include a proximal lumen 315 and a distal lumen 313. As shown in FIG. 14, the proximal lumen 315 may have an inner diameter larger than an inner diameter of the distal lumen 313. A stepped portion or shoulder 311 may define the transition between the proximal lumen 315 and the distal lumen 313. As illustrated in FIG. 14, the inner diameter of the proximal lumen 315 is sized to accommodate the guidewire guide tube 312A as it passes through a portion of the tip member 304A. However, the inner diameter of the distal lumen 313 in FIG. 14 is sized to be smaller than the outer diameter of the guidewire guide tube 312A such that the guidewire guide tube 312A is too large to pass through the distal lumen 313 of the tip member 304A. In addition, in some embodiments, the thickness of the guidewire guide tube 312A may be made smaller than the height of the stepped portion or shoulder 311, e.g., smaller than the difference between the inner diameter of the proximal lumen 315 and the inner diameter of the distal lumen 313. By housing the guidewire guide tube 312A against the shoulder 311, the shoulder 311 can protect the outer coating of the guidewire when the guidewire is inserted proximally from the distal lumen 313 to the proximal lumen 315.


The embodiment illustrated in FIG. 14 may assist the clinician in inserting the guidewire (e.g., the guidewire 235 described above) into the distal end 300A of the catheter assembly. For example, in FIG. 14, the guidewire guide tube 312A may be inserted through the central lumen of the catheter assembly. For example, the guidewire guide tube 312A may pass distally through a portion of the motor, the catheter body, the impeller assembly and cannula housing 302A, and through the proximal lumen 315 of the tip member 304A. The guidewire guide tube 312A may be urged further distally until the distal end of the guidewire guide tube 312A reaches the shoulder 311. When the distal end of the guidewire guide tube 312A reaches the shoulder 311, the shoulder 311 may prevent further insertion of the guidewire guide tube 312 in the distal direction. Because the inner diameter of the distal lumen 313 is smaller than the outer diameter of the guidewire guide tube 312A, the distal end of the guidewire guide tube 312A may be disposed just proximal of the shoulder 311, as shown in FIG. 14.


The clinician may insert the proximal end of the guidewire (such as the guidewire 235 described above) proximally through the distal lumen 313 passing through the rounded tip 310A at the distal end of the tip member 304A. Because the tip member 304A is flexible, the clinician can easily bend or otherwise manipulate the distal end of the tip member 304A to accommodate the small guidewire. Unlike the guidewire guide tube 312A, which may be generally stiffer than the tip member 304A, the clinician may easily deform the tip member 304A to urge the guidewire into the distal lumen 313. Once the guidewire is inserted in the distal lumen 313, the clinician can urge the guidewire proximally past the stepped portion 311 and into the larger guidewire guide tube 312A, which may be positioned within the proximal lumen 315. Furthermore, since most commercial guidewires include a coating (e.g. a hydrophilic or antomicrobial coating, or PTFE coating), the exemplary guide tube and shoulder advantageously avoid damaging or removing the coating. When the wall thickness of the guidewire guide tube 312A is less than the height of the step or shoulder 311, the shoulder 311 may substantially prevent the guidewire guide tube 312A from scraping the exterior coating off of the guidewire. Instead, the guidewire easily passes from the distal lumen 313 to the proximal lumen 315. The guidewire may then be urged proximally through the impeller and catheter assembly until the guidewire protrudes from the proximal end of the system, such as through the proximal guidewire opening 237 described above with reference to FIG. 4.


Although the inventions herein have been described with reference to particular embodiments, it is to be understood that these embodiments are merely illustrative of the principles and applications of the present inventions. It is therefore to be understood that numerous modifications can be made to the illustrative embodiments and that other arrangements can be devised without departing from the spirit and scope of the present inventions as defined by the appended claims. Thus, it is intended that the present application cover the modifications and variations of these embodiments and their equivalents.

Claims
  • 1. A motor assembly for a catheter pump including a drive shaft and an elongate catheter body, the motor assembly comprising: a motor comprising: a motor housing;a rotor and a stator disposed within the motor housing, the rotor configured to turn in response to a stator current conducted through the stator;a drive magnet disposed within the motor housing and mechanically coupled to the rotor; anda motor housing interface adjacent the drive magnet and comprising a securement device;a driven magnet mechanically coupled to the drive shaft extending through the elongate catheter body; anda flow diverter interface adjacent the driven magnet and configured to be coupled to a flow diverter having at least one fluid channel extending distally through the elongate catheter body, the flow diverter interface configured to engage the securement device to position the driven magnet relative to the drive magnet such that the driven magnet is electromagnetically coupled to the drive magnet.
  • 2. The motor assembly of claim 1, wherein the securement device comprises: an annular body; andone or more pins extending radially from the annular body.
  • 3. The motor assembly of claim 2, wherein the flow diverter interface comprises one or more slots into which the one or more pins are respectively inserted when the flow diverter interface engages the securement device.
  • 4. The motor assembly of claim 3, wherein the one or more slots extend at least partially parallel with the drive shaft.
  • 5. The motor assembly of claim 3, wherein the one or more slots extend at least partially tangential to the annular body.
  • 6. The motor assembly of claim 2, wherein the one or more pins are distributed evenly about a circumference of the annular body.
  • 7. The motor assembly of claim 1, wherein the motor housing defines a recess in which the drive magnet is disposed.
  • 8. The motor assembly of claim 1, wherein the drive magnet defines a recess into which the driven magnet is configured to be inserted.
  • 9. The motor assembly of claim 1, wherein the securement device comprises: an annular body; andone or more projections extending radially from the annular body.
  • 10. The motor assembly of claim 1, wherein the flow diverter comprises a chamber in which the driven magnet is disposed, the chamber in fluid communication with the at least one fluid channel.
  • 11. A catheter assembly, comprising: an elongate catheter body having a distal end insertable into a patient, and a proximal end opposite the distal end;a flow diverter coupled to the proximal end of the elongate catheter body, the flow diverter comprising: a chamber in fluid communication with a fluid channel extending distally through the elongate catheter body;a driven magnet mechanically coupled to a drive shaft extending through the elongate catheter body; anda flow diverter interface adjacent the driven magnet; anda motor comprising: a motor housing;a rotor and a stator disposed within the motor housing, the rotor configured to turn in response to a stator current conducted through the stator;a drive magnet disposed within the motor housing and mechanically coupled to the rotor; anda motor housing interface adjacent the drive magnet and comprising a securement device configured to engage the flow diverter interface to position the driven magnet relative to the drive magnet such that the driven magnet is electromagnetically coupled to the drive magnet.
  • 12. The catheter assembly of claim 11, wherein the securement device comprises: an annular body; andone or more pins extending radially from the annular body.
  • 13. The catheter assembly of claim 12, wherein the flow diverter interface comprises one or more slots into which the one or more pins are respectively inserted when the flow diverter interface engages the securement device.
  • 14. The catheter assembly of claim 13, wherein the one or more slots extend at least partially parallel with the drive shaft.
  • 15. The catheter assembly of claim 13, wherein the one or more slots extend at least partially tangential to the annular body.
  • 16. The catheter assembly of claim 12, wherein the one or more pins are distributed evenly about a circumference of the annular body.
  • 17. The catheter assembly of claim 11, wherein the motor housing defines a recess in which the drive magnet is disposed.
  • 18. The catheter assembly of claim 11, wherein the drive magnet defines a recess into which the driven magnet is configured to be inserted.
  • 19. The catheter assembly of claim 11, wherein the securement device comprises: an annular body; andone or more projections extending radially from the annular body.
  • 20. The catheter assembly of claim 11, wherein the driven magnet is disposed in the chamber.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a Continuation of U.S. patent application Ser. No. 16/742,129, filed Jan. 14, 2020, which is a Continuation of U.S. patent application Ser. No. 15/242,024, filed on Aug. 19, 2016, which is a Continuation of U.S. patent application Ser. No. 13/802,468, filed on Mar. 13, 2013, which claims the benefit of priority to U.S. Provisional Application No. 61/667,869, filed on Jul. 3, 2012, titled “MOTOR ASSEMBLY FOR CATHETER PUMP,” the entire contents of which are incorporated herein by reference.

US Referenced Citations (550)
Number Name Date Kind
1902418 Pilgrim Mar 1933 A
2356659 De Paiva Aguiar Aug 1944 A
2649052 Weyer Aug 1953 A
2664050 Abresch Dec 1953 A
2684035 Kemp Jul 1954 A
2776161 Dingman et al. Jan 1957 A
2789511 Doble Apr 1957 A
2896926 Chapman Jul 1959 A
2935068 Donaldson May 1960 A
3080824 Boyd et al. Mar 1963 A
3135943 Richard Jun 1964 A
3455540 Marcmann Jul 1969 A
3510229 Smith May 1970 A
3812812 Hurwitz May 1974 A
3860713 Shema et al. Jan 1975 A
3860968 Shapiro Jan 1975 A
3904901 Renard et al. Sep 1975 A
3995617 Watkins et al. Dec 1976 A
4115040 Knorr Sep 1978 A
4129129 Amrine Dec 1978 A
4135253 Reich et al. Jan 1979 A
4143425 Runge Mar 1979 A
4149535 Volder Apr 1979 A
4155040 Ackerman et al. May 1979 A
4304524 Coxon Dec 1981 A
4382199 Isaacson May 1983 A
4392836 Sugawara Jul 1983 A
4458366 MacGregor et al. Jul 1984 A
4540402 Aigner Sep 1985 A
4560375 Schulte et al. Dec 1985 A
4589822 Clausen et al. May 1986 A
4625712 Wampler Dec 1986 A
4655745 Corbett Apr 1987 A
4686982 Nash Aug 1987 A
4696667 Masch Sep 1987 A
4704121 Moise Nov 1987 A
4728319 Masch Mar 1988 A
4753221 Kensey et al. Jun 1988 A
4769006 Papantonakos Sep 1988 A
4817586 Wampler Apr 1989 A
4846152 Wampler et al. Jul 1989 A
4895557 Moise et al. Jan 1990 A
4900227 Trouplin Feb 1990 A
4902272 Milder et al. Feb 1990 A
4906229 Wampler Mar 1990 A
4908012 Moise et al. Mar 1990 A
4919647 Nash Apr 1990 A
4944722 Carriker et al. Jul 1990 A
4955856 Phillips Sep 1990 A
4957504 Chardack Sep 1990 A
4964864 Summers et al. Oct 1990 A
4969865 Hwang et al. Nov 1990 A
4976270 Parl et al. Dec 1990 A
4985014 Orejola Jan 1991 A
4994017 Yozu Feb 1991 A
4995857 Arnold Feb 1991 A
5000177 Hoffmann et al. Mar 1991 A
5021048 Buckholtz Jun 1991 A
5045072 Castillo et al. Sep 1991 A
5049134 Golding et al. Sep 1991 A
5061256 Wampler Oct 1991 A
5089016 Millner et al. Feb 1992 A
5092844 Schwartz et al. Mar 1992 A
5098256 Smith Mar 1992 A
5106368 Uldall et al. Apr 1992 A
5112200 Isaacson et al. May 1992 A
5112292 Hwang et al. May 1992 A
5112349 Summers et al. May 1992 A
5129883 Black Jul 1992 A
5142155 Mauze et al. Aug 1992 A
5145637 Richardson et al. Sep 1992 A
5147186 Buckholtz Sep 1992 A
5163910 Schwartz et al. Nov 1992 A
5169378 Figuera Dec 1992 A
5171212 Buck et al. Dec 1992 A
5190528 Fonger et al. Mar 1993 A
5195960 Hossain et al. Mar 1993 A
5201679 Velte et al. Apr 1993 A
5211546 Isaacson et al. May 1993 A
5221270 Parker Jun 1993 A
5234407 Teirstein et al. Aug 1993 A
5234416 MacAulay et al. Aug 1993 A
5290227 Pasque Mar 1994 A
5300112 Barr Apr 1994 A
5308354 Zacca et al. May 1994 A
5312341 Turi May 1994 A
5344443 Palma et al. Sep 1994 A
5346458 Affeld Sep 1994 A
5346568 Gsellmann Sep 1994 A
5360317 Clausen et al. Nov 1994 A
5376114 Jarvik Dec 1994 A
5393197 Lemont et al. Feb 1995 A
5393207 Maher et al. Feb 1995 A
5405341 Martin Apr 1995 A
5405383 Barr Apr 1995 A
5437541 Vainrub Aug 1995 A
5449342 Hirose et al. Sep 1995 A
5458459 Hubbard et al. Oct 1995 A
5490763 Abrams et al. Feb 1996 A
5505701 Anaya Fernandez De Lomana Apr 1996 A
5527159 Bozeman et al. Jun 1996 A
5533957 Aldea Jul 1996 A
5534287 Lukic Jul 1996 A
5554114 Wallace et al. Sep 1996 A
5588812 Taylor et al. Dec 1996 A
5601418 Ohara et al. Feb 1997 A
5609574 Kaplan et al. Mar 1997 A
5613476 Oi Mar 1997 A
5613935 Jarvik Mar 1997 A
5643226 Cosgrove et al. Jul 1997 A
5678306 Bozeman et al. Oct 1997 A
5692882 Bozeman et al. Dec 1997 A
5702418 Ravenscroft Dec 1997 A
5704926 Sutton Jan 1998 A
5707218 Maher et al. Jan 1998 A
5722930 Larson et al. Mar 1998 A
5725513 Ju et al. Mar 1998 A
5725570 Heath Mar 1998 A
5730628 Hawkins Mar 1998 A
5735897 Buirge Apr 1998 A
5738649 Macoviak Apr 1998 A
5741234 Aboul-Hosn Apr 1998 A
5741429 Donadio et al. Apr 1998 A
5746709 Rom et al. May 1998 A
5749855 Reitan May 1998 A
5755784 Jarvik May 1998 A
5776111 Tesio Jul 1998 A
5776161 Globerman Jul 1998 A
5776190 Jarvis Jul 1998 A
5779721 Nash Jul 1998 A
5807311 Palestrant Sep 1998 A
5814011 Corace Sep 1998 A
5824070 Jarvik Oct 1998 A
5851174 Jarvik et al. Dec 1998 A
5859482 Crowell et al. Jan 1999 A
5868702 Stevens et al. Feb 1999 A
5868703 Bertolero et al. Feb 1999 A
5888241 Jarvik Mar 1999 A
5888242 Antaki et al. Mar 1999 A
5911685 Siess et al. Jun 1999 A
5921913 Siess Jul 1999 A
5941813 Sievers et al. Aug 1999 A
5951263 Taylor et al. Sep 1999 A
5957941 Ream Sep 1999 A
5964694 Siess et al. Oct 1999 A
6007478 Siess et al. Dec 1999 A
6007479 Rottenberg et al. Dec 1999 A
6015272 Antaki et al. Jan 2000 A
6015434 Yamane Jan 2000 A
6018208 Maher et al. Jan 2000 A
6027863 Donadio Feb 2000 A
6056705 Stigar-Brown May 2000 A
6056719 Mickley May 2000 A
6058593 Siess May 2000 A
6059760 Sandmore et al. May 2000 A
6068610 Ellis et al. May 2000 A
6071093 Hart Jun 2000 A
6083260 Aboul-Hosn Jul 2000 A
6086527 Talpade Jul 2000 A
6086570 Aboul-Hosn et al. Jul 2000 A
6106494 Saravia et al. Aug 2000 A
6113536 Aboul-Hosn et al. Sep 2000 A
6123659 Le Blanc et al. Sep 2000 A
6123725 Aboul-Hosn Sep 2000 A
6132363 Freed et al. Oct 2000 A
6136025 Barbut et al. Oct 2000 A
6139487 Siess Oct 2000 A
6152704 Aboul-Hosn et al. Nov 2000 A
6162194 Shipp Dec 2000 A
6176822 Nix et al. Jan 2001 B1
6176848 Rau et al. Jan 2001 B1
6186665 Maher et al. Feb 2001 B1
6190304 Downey et al. Feb 2001 B1
6190537 Kanataev et al. Feb 2001 B1
6200260 Bolling Mar 2001 B1
6210133 Aboul-Hosn et al. Apr 2001 B1
6210318 Lederman Apr 2001 B1
6210397 Aboul-Hosn et al. Apr 2001 B1
6214846 Elliott Apr 2001 B1
6217541 Yu Apr 2001 B1
6227797 Watterson et al. May 2001 B1
6228063 Aboul-Hosn May 2001 B1
6234960 Aboul-Hosn et al. May 2001 B1
6234995 Peacock May 2001 B1
6244835 Antaki Jun 2001 B1
6245007 Bedingham et al. Jun 2001 B1
6245026 Campbell et al. Jun 2001 B1
6247892 Kazatchkov et al. Jun 2001 B1
6248091 Voelker Jun 2001 B1
6254359 Aber Jul 2001 B1
6254564 Wilk et al. Jul 2001 B1
6287319 Aboul-Hosn et al. Sep 2001 B1
6287336 Globerman et al. Sep 2001 B1
6295877 Aboul-Hosn et al. Oct 2001 B1
6299635 Frantzen Oct 2001 B1
6305962 Maher et al. Oct 2001 B1
6387037 Bolling et al. May 2002 B1
6395026 Aboul-Hosn et al. May 2002 B1
6413222 Pantages et al. Jul 2002 B1
6422990 Prem Jul 2002 B1
6425007 Messinger Jul 2002 B1
6428464 Bolling Aug 2002 B1
6447441 Yu et al. Sep 2002 B1
6454775 Demarais et al. Sep 2002 B1
6468298 Pelton Oct 2002 B1
6503224 Forman et al. Jan 2003 B1
6508777 Macoviak et al. Jan 2003 B1
6508787 Erbel et al. Jan 2003 B2
6517315 Belady Feb 2003 B2
6517528 Pantages et al. Feb 2003 B1
6527699 Goldowsky Mar 2003 B1
6532964 Aboul-Hosn et al. Mar 2003 B2
6533716 Schmitz-Rode et al. Mar 2003 B1
6544216 Sammler et al. Apr 2003 B1
6547519 DeBlanc et al. Apr 2003 B2
6565588 Clement et al. May 2003 B1
6565598 Lootz May 2003 B1
6609883 Woodard et al. Aug 2003 B2
6610004 Viole et al. Aug 2003 B2
6613008 Aboul-Hosn et al. Sep 2003 B2
6616323 McGill Sep 2003 B2
6623420 Reich et al. Sep 2003 B2
6623475 Siess Sep 2003 B1
6641093 Coudrais Nov 2003 B2
6641558 Aboul-Hosn et al. Nov 2003 B1
6645241 Strecker Nov 2003 B1
6652548 Evans et al. Nov 2003 B2
6660014 Demarais et al. Dec 2003 B2
6673105 Chen Jan 2004 B1
6692318 McBride Feb 2004 B2
6702830 Demarais et al. Mar 2004 B1
6709418 Aboul-Hosn et al. Mar 2004 B1
6716189 Jarvik et al. Apr 2004 B1
6749598 Keren et al. Jun 2004 B1
6776578 Belady Aug 2004 B2
6776794 Hong et al. Aug 2004 B1
6783328 Lucke et al. Aug 2004 B2
6790171 Gruendeman et al. Sep 2004 B1
6794784 Takahashi et al. Sep 2004 B2
6794789 Siess et al. Sep 2004 B2
6814713 Aboul-Hosn et al. Nov 2004 B2
6817836 Nose et al. Nov 2004 B2
6818001 Wulfman et al. Nov 2004 B2
6866625 Ayre et al. Mar 2005 B1
6866805 Hong et al. Mar 2005 B2
6887215 McWeeney May 2005 B2
6889082 Bolling et al. May 2005 B2
6901289 Dahl et al. May 2005 B2
6926662 Aboul-Hosn et al. Aug 2005 B1
6935344 Aboul-Hosn et al. Aug 2005 B1
6942611 Siess Sep 2005 B2
6949066 Bearnson et al. Sep 2005 B2
6966748 Woodard et al. Nov 2005 B2
6972956 Franz et al. Dec 2005 B2
6974436 Aboul-Hosn et al. Dec 2005 B1
6981942 Khaw et al. Jan 2006 B2
6984392 Bechert et al. Jan 2006 B2
7010954 Siess et al. Mar 2006 B2
7011620 Siess Mar 2006 B1
7014417 Salomon Mar 2006 B2
7022100 Aboul-Hosn et al. Apr 2006 B1
7027875 Siess et al. Apr 2006 B2
7037069 Arnold et al. May 2006 B2
7070555 Siess Jul 2006 B2
7122019 Kesten et al. Oct 2006 B1
7125376 Viole et al. Oct 2006 B2
7144365 Bolling et al. Dec 2006 B2
7150711 Nusser et al. Dec 2006 B2
7160243 Medvedev Jan 2007 B2
7172551 Leasure Feb 2007 B2
7175588 Morello Feb 2007 B2
7229258 Wood et al. Jun 2007 B2
7241257 Ainsworth et al. Jul 2007 B1
7262531 Li et al. Aug 2007 B2
7264606 Jarvik et al. Sep 2007 B2
7267667 Houde et al. Sep 2007 B2
7284956 Nose et al. Oct 2007 B2
7288111 Holloway et al. Oct 2007 B1
7290929 Smith et al. Nov 2007 B2
7329236 Kesten et al. Feb 2008 B2
7331921 Viole et al. Feb 2008 B2
7335192 Keren et al. Feb 2008 B2
7341570 Keren et al. Mar 2008 B2
7381179 Aboul-Hosn et al. Jun 2008 B2
7393181 McBride et al. Jul 2008 B2
7469716 Parrino et al. Dec 2008 B2
7491163 Viole et al. Feb 2009 B2
7534258 Gomez et al. May 2009 B2
7605298 Bechert et al. Oct 2009 B2
7619560 Penna et al. Nov 2009 B2
7633193 Masoudipour et al. Dec 2009 B2
7645225 Medvedev et al. Jan 2010 B2
7657324 Westlund et al. Feb 2010 B2
7682673 Houston et al. Mar 2010 B2
7722568 Lenker et al. May 2010 B2
7731675 Aboul-Hosn et al. Jun 2010 B2
7736296 Siess et al. Jun 2010 B2
7758521 Morris et al. Jul 2010 B2
7766892 Keren et al. Aug 2010 B2
7780628 Keren et al. Aug 2010 B1
7785246 Aboul-Hosn et al. Aug 2010 B2
7811279 John Oct 2010 B2
7819833 Ainsworth et al. Oct 2010 B2
7820205 Takakusagi et al. Oct 2010 B2
7828710 Shifflette Nov 2010 B2
7842976 Fujii et al. Nov 2010 B2
7918828 Lundgaard et al. Apr 2011 B2
7927068 McBride et al. Apr 2011 B2
7935102 Breznock et al. May 2011 B2
7942804 Khaw May 2011 B2
7942844 Moberg et al. May 2011 B2
7955365 Doty Jun 2011 B2
7993259 Kang et al. Aug 2011 B2
7998054 Bolling Aug 2011 B2
7998190 Gharib et al. Aug 2011 B2
8012079 Delgado et al. Sep 2011 B2
8025647 Siess et al. Sep 2011 B2
8079948 Shifflette Dec 2011 B2
8110267 Houston et al. Feb 2012 B2
8114008 Hidaka et al. Feb 2012 B2
8123669 Siess et al. Feb 2012 B2
8177703 Smith et al. May 2012 B2
8206350 Mann et al. Jun 2012 B2
8209015 Glenn Jun 2012 B2
8216122 Kung et al. Jul 2012 B2
8235943 Breznock et al. Aug 2012 B2
8236040 Mayberry et al. Aug 2012 B2
8236044 Robaina Aug 2012 B2
8255050 Mohl Aug 2012 B2
8257312 Duffy Sep 2012 B2
8262619 Chebator et al. Sep 2012 B2
8277470 Demarais et al. Oct 2012 B2
8317715 Belleville et al. Nov 2012 B2
8329913 Murata et al. Dec 2012 B2
8333687 Farnan et al. Dec 2012 B2
8348991 Weber et al. Jan 2013 B2
8364278 Pianca et al. Jan 2013 B2
8376707 McBride et al. Feb 2013 B2
8382818 Davis et al. Feb 2013 B2
8388565 Shifflette Mar 2013 B2
8409128 Ferrari Apr 2013 B2
8414645 Dwork et al. Apr 2013 B2
8439859 Pfeffer et al. May 2013 B2
8449443 Rodefeld et al. May 2013 B2
8485961 Campbell et al. Jul 2013 B2
8489190 Pfeffer et al. Jul 2013 B2
8535211 Campbell et al. Sep 2013 B2
8540615 Aboul-Hosn et al. Sep 2013 B2
8545379 Marseille et al. Oct 2013 B2
8545380 Farnan et al. Oct 2013 B2
8579858 Reitan et al. Nov 2013 B2
8585572 Mehmanesh Nov 2013 B2
8591393 Walters et al. Nov 2013 B2
8597170 Walters et al. Dec 2013 B2
8617239 Reitan Dec 2013 B2
8684904 Campbell et al. Apr 2014 B2
8690749 Nunez Apr 2014 B1
8721516 Scheckel May 2014 B2
8721517 Zeng et al. May 2014 B2
8727959 Reitan et al. May 2014 B2
8734331 Evans et al. May 2014 B2
8734334 Haramaty et al. May 2014 B2
8784441 Rosenbluth et al. Jul 2014 B2
8790236 Larose et al. Jul 2014 B2
8795576 Tao et al. Aug 2014 B2
8801590 Mohl Aug 2014 B2
8814776 Hastie et al. Aug 2014 B2
8814933 Siess Aug 2014 B2
8849398 Evans et al. Sep 2014 B2
8944748 Liebing Feb 2015 B2
8992406 Corbett Mar 2015 B2
8998792 Scheckel Apr 2015 B2
9028216 Schumacher et al. May 2015 B2
9089634 Schumacher et al. Jul 2015 B2
9089670 Scheckel Jul 2015 B2
9162017 Evans et al. Oct 2015 B2
9217442 Wiessler et al. Dec 2015 B2
9308302 Zeng Apr 2016 B2
9314558 Er Apr 2016 B2
9327067 Zeng et al. May 2016 B2
9328741 Liebing May 2016 B2
9358330 Schumacher Jun 2016 B2
20020107506 Mcguckin et al. Aug 2002 A1
20020111663 Dahl et al. Aug 2002 A1
20020151761 Viole et al. Oct 2002 A1
20020169413 Keren et al. Nov 2002 A1
20030018380 Craig et al. Jan 2003 A1
20030023201 Aboul-Hosn et al. Jan 2003 A1
20030100816 Siess May 2003 A1
20030135086 Khaw et al. Jul 2003 A1
20030187322 Siess Oct 2003 A1
20030205233 Aboul-Hosn et al. Nov 2003 A1
20030208097 Aboul-Hosn et al. Nov 2003 A1
20030231959 Snider Dec 2003 A1
20040019251 Viole et al. Jan 2004 A1
20040044266 Siess et al. Mar 2004 A1
20040101406 Hoover May 2004 A1
20040113502 Li et al. Jun 2004 A1
20040236173 Viole et al. Nov 2004 A1
20050049664 Harris et al. Mar 2005 A1
20050049696 Siess et al. Mar 2005 A1
20050085683 Bolling et al. Apr 2005 A1
20050090883 Westlund et al. Apr 2005 A1
20050095124 Arnold et al. May 2005 A1
20050113631 Bolling et al. May 2005 A1
20050135942 Wood et al. Jun 2005 A1
20050165466 Morris et al. Jul 2005 A1
20050250975 Carrier et al. Nov 2005 A1
20050277912 John Dec 2005 A1
20060005886 Parrino et al. Jan 2006 A1
20060018943 Bechert et al. Jan 2006 A1
20060036127 Delgado et al. Feb 2006 A1
20060058869 Olson et al. Mar 2006 A1
20060062672 McBride et al. Mar 2006 A1
20060063965 Aboul-Hosn et al. Mar 2006 A1
20060089521 Chang Apr 2006 A1
20060155158 Aboul-Hosn Jul 2006 A1
20060264695 Viole et al. Nov 2006 A1
20060270894 Viole et al. Nov 2006 A1
20070100314 Keren et al. May 2007 A1
20070156006 Smith et al. Jul 2007 A1
20070203442 Bechert et al. Aug 2007 A1
20070208298 Ainsworth et al. Sep 2007 A1
20070233270 Weber et al. Oct 2007 A1
20070282417 Houston et al. Dec 2007 A1
20080004645 To et al. Jan 2008 A1
20080004690 Robaina Jan 2008 A1
20080031953 Takakusagi et al. Feb 2008 A1
20080093764 Ito et al. Apr 2008 A1
20080103442 Kesten et al. May 2008 A1
20080103516 Wulfman et al. May 2008 A1
20080103591 Siess May 2008 A1
20080114339 McBride et al. May 2008 A1
20080119943 Armstrong et al. May 2008 A1
20080132748 Shifflette Jun 2008 A1
20080275290 Viole et al. Nov 2008 A1
20080306327 Shifflette Dec 2008 A1
20090018567 Escudero et al. Jan 2009 A1
20090023975 Marseille et al. Jan 2009 A1
20090024085 To et al. Jan 2009 A1
20090060743 McBride et al. Mar 2009 A1
20090062597 Shifflette Mar 2009 A1
20090073037 Penna et al. Mar 2009 A1
20090093764 Pfeffer Apr 2009 A1
20090093765 Glenn Apr 2009 A1
20090093796 Pfeffer et al. Apr 2009 A1
20090099638 Grewe Apr 2009 A1
20090112312 Larose et al. Apr 2009 A1
20090118567 Siess May 2009 A1
20090163864 Breznock et al. Jun 2009 A1
20090167679 Klier et al. Jul 2009 A1
20090171137 Farnan et al. Jul 2009 A1
20090182188 Marseille et al. Jul 2009 A1
20090234378 Escudero et al. Sep 2009 A1
20100016960 Bolling Jan 2010 A1
20100030186 Stivland Feb 2010 A1
20100041939 Siess Feb 2010 A1
20100047099 Miyazaki et al. Feb 2010 A1
20100087773 Ferrari Apr 2010 A1
20100127871 Pontin May 2010 A1
20100191035 Kang et al. Jul 2010 A1
20100197994 Mehmanesh Aug 2010 A1
20100210895 Aboul-Hosn et al. Aug 2010 A1
20100268017 Siess et al. Oct 2010 A1
20100274330 Burwell et al. Oct 2010 A1
20100286210 Murata et al. Nov 2010 A1
20100286791 Goldsmith Nov 2010 A1
20110004045 Larsen et al. Jan 2011 A1
20110004046 Campbell et al. Jan 2011 A1
20110004291 Davis et al. Jan 2011 A1
20110021865 Aboul-Hosn et al. Jan 2011 A1
20110034874 Reitan et al. Feb 2011 A1
20110071338 McBride et al. Mar 2011 A1
20110076439 Zeilon Mar 2011 A1
20110152906 Escudero et al. Jun 2011 A1
20110152907 Escudero et al. Jun 2011 A1
20110236210 McBride et al. Sep 2011 A1
20110237863 Ricci et al. Sep 2011 A1
20110238172 Akdis Sep 2011 A1
20110257462 Rodefeld et al. Oct 2011 A1
20110270182 Breznock et al. Nov 2011 A1
20110275884 Scheckel Nov 2011 A1
20120004495 Bolling et al. Jan 2012 A1
20120029265 Larose et al. Feb 2012 A1
20120045352 Lawyer et al. Feb 2012 A1
20120059213 Spence et al. Mar 2012 A1
20120142994 Toellner Jun 2012 A1
20120172654 Bates Jul 2012 A1
20120172655 Campbell et al. Jul 2012 A1
20120172656 Walters et al. Jul 2012 A1
20120178985 Walters et al. Jul 2012 A1
20120178986 Campbell et al. Jul 2012 A1
20120184803 Simon et al. Jul 2012 A1
20120224970 Schumacher et al. Sep 2012 A1
20120226097 Smith et al. Sep 2012 A1
20120234411 Scheckel et al. Sep 2012 A1
20120237357 Schumacher et al. Sep 2012 A1
20120245404 Smith et al. Sep 2012 A1
20120265002 Roehn et al. Oct 2012 A1
20130031936 Goncalves Ferreira et al. Feb 2013 A1
20130039465 Okuno Feb 2013 A1
20130041202 Toellner et al. Feb 2013 A1
20130053622 Corbett Feb 2013 A1
20130053623 Evans et al. Feb 2013 A1
20130066140 McBride et al. Mar 2013 A1
20130085318 Toellner et al. Apr 2013 A1
20130085319 Evans et al. Apr 2013 A1
20130096364 Reichenbach et al. Apr 2013 A1
20130103063 Escudero et al. Apr 2013 A1
20130106212 Nakazumi et al. May 2013 A1
20130129503 McBride et al. May 2013 A1
20130138205 Kushwaha et al. May 2013 A1
20130204362 Toellner et al. Aug 2013 A1
20130209292 Baykut et al. Aug 2013 A1
20130237744 Pfeffer et al. Sep 2013 A1
20130245360 Schumacher et al. Sep 2013 A1
20130303831 Evans et al. Nov 2013 A1
20130303969 Keenan et al. Nov 2013 A1
20130303970 Keenan et al. Nov 2013 A1
20130331639 Campbell et al. Dec 2013 A1
20130345492 Pfeffer et al. Dec 2013 A1
20140005467 Farnan et al. Jan 2014 A1
20140010686 Tanner et al. Jan 2014 A1
20140012065 Fitzgerald et al. Jan 2014 A1
20140067057 Callaway et al. Mar 2014 A1
20140088455 Christensen et al. Mar 2014 A1
20140148638 Larose et al. May 2014 A1
20140163664 Goldsmith Jun 2014 A1
20140255176 Bredenbreuker et al. Sep 2014 A1
20140275725 Schenck et al. Sep 2014 A1
20140275726 Zeng Sep 2014 A1
20140301822 Scheckel Oct 2014 A1
20140303596 Schumacher et al. Oct 2014 A1
20150025558 Wulfman et al. Jan 2015 A1
20150051435 Siess et al. Feb 2015 A1
20150051436 Spanier et al. Feb 2015 A1
20150080743 Siess et al. Mar 2015 A1
20150087890 Spanier et al. Mar 2015 A1
20150141738 Toellner et al. May 2015 A1
20150141739 Hsu et al. May 2015 A1
20150151032 Voskoboynikov et al. Jun 2015 A1
20150209498 Franano et al. Jul 2015 A1
20150224970 Yasui et al. Aug 2015 A1
20150250935 Anderson et al. Sep 2015 A1
20150290372 Muller et al. Oct 2015 A1
20150343179 Schumacher et al. Dec 2015 A1
20160184500 Zeng Jun 2016 A1
20160250399 Tiller et al. Sep 2016 A1
20160250400 Schumacher Sep 2016 A1
20160256620 Scheckel et al. Sep 2016 A1
Foreign Referenced Citations (98)
Number Date Country
2256427 Oct 1998 CA
2322012 Sep 1999 CA
2367469 Oct 2000 CA
2407938 Nov 2001 CA
2480467 Aug 2003 CA
2701870 Apr 2009 CA
19613565 Jul 1997 DE
10059714 May 2002 DE
112004001809 Nov 2006 DE
0193762 Sep 1986 EP
0364293 Apr 1990 EP
0453234 Oct 1991 EP
0533432 Mar 1993 EP
1207934 May 2002 EP
1591079 Nov 2005 EP
2151257 Feb 2010 EP
2263732 Dec 2010 EP
2298374 Mar 2011 EP
2427230 Mar 2012 EP
2267800 Nov 1975 FR
886219 Jan 1962 GB
2239675 Jul 1991 GB
S4823295 Mar 1973 JP
S58190448 Nov 1983 JP
H08500512 Jan 1996 JP
H08501466 Feb 1996 JP
H09114101 May 1997 JP
10099447 Apr 1998 JP
2002505168 Feb 2002 JP
2004514506 May 2004 JP
2011000620 Jan 2011 JP
2011157961 Aug 2011 JP
9405347 Mar 1994 NO
9944651 Sep 1999 NO
0019097 Apr 2000 NO
500877 Sep 2002 TW
8904644 Jun 1989 WO
8905164 Jun 1989 WO
9406486 Mar 1994 WO
9526695 Oct 1995 WO
9715228 May 1997 WO
9737697 Oct 1997 WO
9737698 Oct 1997 WO
9900368 Jan 1999 WO
9902204 Jan 1999 WO
9916387 Apr 1999 WO
9937352 Jul 1999 WO
9944670 Sep 1999 WO
9959652 Nov 1999 WO
9965546 Dec 1999 WO
0012148 Mar 2000 WO
0018448 Apr 2000 WO
0037139 Jun 2000 WO
0038591 Jul 2000 WO
0041612 Jul 2000 WO
0043053 Jul 2000 WO
0043062 Jul 2000 WO
0045874 Aug 2000 WO
0061207 Oct 2000 WO
0069489 Nov 2000 WO
0117581 Mar 2001 WO
0124867 Apr 2001 WO
0178807 Oct 2001 WO
0183016 Nov 2001 WO
02070039 Sep 2002 WO
03048582 Jun 2003 WO
03068303 Aug 2003 WO
03070299 Aug 2003 WO
03103745 Dec 2003 WO
2005089674 Sep 2005 WO
2005123158 Dec 2005 WO
2006034158 Mar 2006 WO
2006046779 May 2006 WO
2006051023 May 2006 WO
2007112033 Oct 2007 WO
2008034068 Mar 2008 WO
2009073037 Jun 2009 WO
2009076460 Jun 2009 WO
2010063494 Jun 2010 WO
2010127871 Nov 2010 WO
2010133567 Nov 2010 WO
2010149393 Dec 2010 WO
2011003043 Jan 2011 WO
2011035926 Mar 2011 WO
2011035927 Mar 2011 WO
2011035929 Mar 2011 WO
2011039091 Apr 2011 WO
2011076439 Jun 2011 WO
2011089022 Jul 2011 WO
2012007140 Jan 2012 WO
2012007141 Jan 2012 WO
2012094525 Jul 2012 WO
2012094534 Jul 2012 WO
2013148697 Oct 2013 WO
2013160407 Oct 2013 WO
2013173245 Nov 2013 WO
2014019274 Feb 2014 WO
2015063277 May 2015 WO
Non-Patent Literature Citations (116)
Entry
“In response to the Proprietor's letter of Jul. 18, 2012” from Hoffmann Eitle dated Oct. 24, 2012, Opposition, EP 2 234 658 81, Proprietor: AIS GmbH Aachen Innovative Solutions (DE), Opponent Dr. Niels Holder (DE), 7 pages.
“Response to the Summons dated Jun. 14, 2013:” from Fish & Richardson P.C., dated Oct. 7, 2013, Opposition against EP 2 047 872 81, 12 pages.
“Responsive to the Summons dated Aug. 26, 2013:” from Fish & Richardson P.C., dated Oct. 7, 2013, Opposition against EP 2 234 658 81, 9 pages.
1st Auxiliary Application dated Oct. 11, 2013, European Application No. 07019657.1, 23 pages Facts of the Case and Petitions, dated Feb. 7, 2014, European Application No. 04763480.3, 13 pages.
Aboul-Hosn et al. ,“The Hemopump: Clinical Results and Future Applications”, Assisted Circulation 4, 1995, in 14 pages.
Compendium of Technical and Scientific Information for the HEMOPUMP Temporary Cardiac Assist System, Johnson & Johnson Interventional Systems, 1988, in 15 pages.
Decision on Rejection of the objection, dated Oct. 1, 2014, European Application No. 04763480.3, 3 pages.
Decision rejecting the opposition (EPC Art. 101(2), dated Oct. 1, 2014, European Application No. 07 019 657.1, 13 pages.
Dekker et al. ,“Efficacy of a New Intraaortic Propeller Pump vs the Intraaortic Balloon Pump, An Animal Study”, Chest, Jun. 2003, vol. 123, No. 6, pp. 2089-2095.
Extended European Search Report received in European Patent Application No. 13813867, dated Feb. 26, 2016, in 6 pages.
Fact and Arguments from Hoffmann Eitle, Opposition, EP 2 234 658 81, Proprietor: AIS GmbH Aachen Innovative Solutions (DE), Opponent: Dr. Niels Holder (DE), dated Feb. 3, 2012; 29 pages.
Fact and Arguments from Hoffmann Eitle. Opposition, EP 2 047 872 81, Proprietor: AIS GmbH Aachen Innovative Solutions (DE), Opponent: Dr. Niels Holder (DE), dated Jun. 8, 2011; 32 pages.
Facts and Ground for the Opposition dated Oct. 17, 2012, European Application No. 04763480.3, 43 pages.
Facts of the Case and Petitions, dated Oct. 1, 2014, European Application No. 04763480.3, 16 pages.
Federal and Drug Administration 51 O(k) Summary for Predicate Device IMPELLA 2.5 (K112892), prepared Sep. 5, 2012.
International Preliminary Report on Patentability and Written Opinion received in International Patent Application No. PCT/US2014/020878, dated Sep. 15, 2015, in 8 pages.
International Search Report and Written Opinion received in International Patent Application NoPCT/US2014/020878, dated May 7, 2014, in 13 pages.
International Search Report and Written Opinion received in International Patent Application No. PCT/US2015/025960, dated Sep. 3, 2015, in 15 pages.
International Search Report and Written Opinion received in International Patent Application No. PCT/US2015/026013, dated Jul. 8, 2015, in 12 pages.
International Search Report and Written Opinion received in International Patent Application No. PCT/US2015/026014, dated Jul. 15, 2015, in 13 pages.
International Search Report and Written Opinion received in International Patent Application No. PCT/US2015/026025, dated Jul. 20, 2015, in 12 pages.
International Search Report and Written Opinion received in International Patent Application No. PCT/US2015/045370, dated Nov. 18, 2015, in 12 pages.
JOMED Reitan Catheter Pump RCP, Feb. 18, 2003, in 4 pages.
JOMED Reitan Catheter Pump RCP, Percutaneous Circulatory Support, in 10 pages, believed to be published prior to Oct. 15, 2003.
Kunst et al. ,“Integrated unit for programmable control of the 21 F Hemopump and registration of physiological signals,” Medical & Biological Engineering & Computing, Nov. 1994, pp. 694-696.
Impella CP®—Instructions for Use & Clinical Reference Manual (United States only), Abiomed, Inc., Jul. 2014, 148 pages, www.abiomed.com.
Impella LD® with the Impella® Controller—Circulatory Support System—Instructions for Use & Clinical Reference Manual (United States only), Abiomed, Inc., Sep. 2010, 132 pages, www.abiomed.com.
Minimally Invasive Cardiac Assist JOMED Catheter Pump™. in 6 pages.
Motion to dismiss the objection by Dr. Niels Holder dated Jan. 17, 2012 to EPO in European Patent No. 2 04 7 872 B 1, 12 pages.
Nullity Action against the owner of the German part DE 50 2007 005 015.6 of European patent EP 2 04 7 872 81, dated Jul. 13, 2015, in 61 pages.
Opinion on behalf of the Opponent dated Aug. 26, 2013, filed with the European Patent Office in European Application No. 04763480.3 (EP Patent No. 1 651 290 81 ), 23 pages.
Opposition by Dr. Niels Holder dated Jul. 18, 2012 to EPO in European Patent No. 2 234 658 81, 14 pages.
Opposition Opinion of EP 2 234 658, dated Jan. 20, 2014; 3 pages.
Reitan,Evaluation of a New Percutaneous Cardiac Assist Device, Department of Cardiology, Faculty of Medicine, Lund University, Sweden, 2002, in 172 pages.
Reply to the Objection by Thoratec Corporation of Oct. 17, 2012, from the European Patent Office dated Mar. 22, 2013 , European Patent No. 1 651 290, 14 pages.
Response to Memorandum of Aug. 26, 2013 with the invitation to an oral hearing, dated Oct. 11, 2013, European Patent No. 2 234 658, 28 pages.
Rothman, “The Reitan Catheter Pump: A New Versatile Approach for Hemodynamic Support”, London Chest Hospital Barts & The London NHS Trust, Oct. 22-27, 2006 (TCT 2006: Transcatheter Cardiovascular Therapeutics 181h Annual Scientific Symposium, Final Program), in 48 pages.
Siess et al. ,“Basic Design Criteria for Rotary Blood Pumps”, Rotary Blood Pumps, 2000, in 15 pages.
Siess et al. ,“From a Lab Type to a Product: A Retrospective View on Impella'S Assist Technology”, Artificial Organs, 2001, vol. 25, No. 5, pp. 414-421.
Siess et al., “System analysis and development of intravascular rotation pumps for cardiac assist,” Dissertation, Shaker Verlag, Aachen, 1999, 39 pages.
Sim et al. ,“Concept, Realization, and First In Vitro Testing of an Intraarterial Microaxial Blood Pump”, Artificial Organs, 1995, vol. 19, No. 7, pp. 644-652.
Sim et al. ,“Hydraulic refinement of an intraarterial microaxial blood pump”, The International Journal of Artificial Organs, 1995, vol. 18, No. 5, pp. 273-285.
Sim, “Systemanalyse und Entwicklung intravasaler Rotationspumpen zur Herzunterstutzung”, Helmholtz-Institut fur Blomedizinische Technik an der RWTH Aachen, Jun. 24, 1998, in 105 pages.
Statement of Appeal, dated Feb. 6, 2015, European Patent No. 1 651 290, Opponent and Appellant Thoratec Corporation, 30 pages.
Stolinski et al. ,“The heart-pump interaction: effects of a microaxial blood pump,” International Journal of Artificial Organs, 2002, pp. 1082-1088, vol. 25, Issue 11.
Synopse zu Anspruchen 1 bis 5 der EP 2 047 872, in 11 pages.
“Statistical Analysis and Clinical Experience with the Recover® Pump Systems”, Impella CardioSystems GmbH, 2 sheets.
Abiomed—Recovering hearts. Saving lives., Impella 2.5 System, Instructions for Use, Jul. 2007 86 sheets.
Abiomed, “Impella 5.0 with the Impella Console, Circulatory Support System, Instructions for Use & Clinical Reference Manual,” Jun. 2010, in 122 pages.
Barras CDJ, Myers KA. Nitinol-Its Use in vascular Surgery and Other Applications. Eur J. Vasc Endovasc Surg 2000; 19:564-9.
Sharony, R. et al. Right heart support during off-pump coronary artery surgery—a multicenter study. Heart Surg Forum. 2002;5(1):13-16.
Biscarini A, Mazzolai G., Tuissi A ,“Enhanced nitinol properties for biomedical applications,” Recent Patents on Biomedical Engineering 2008; 1 (3): 180-96.
Cardiovascular Diseases (CVDs) Fact Sheet No. 317. World Health Organization. [Online] Sep. 2011 http://www.who.int/mediacentre/factsheets/fs317/en/index. html, accessed on Aug. 29, 2012.
Duerig T, Pelton A, Stockel D. “An Overview of nitinol Medical Applications ,” Mat Sci Eng 1999: 149-160.
European Search Report received from the European Patent Office in EP Application No. EP 05799883.3 dated May 10, 2011, 4 pages.
Extended European Search Report received from the European Patent Office in European Patent Application No. EP 07753903.9, dated Oct. 8, 2012, 7 pages.
Extended European Search Report received in European Patent Application No. 13813687.4, dated Feb. 24, 2016, in 6 pages.
Extended European Search Report received in European Patent Application No. 14 764392.8, dated Oct. 27, 2016, in 7 pages.
Extended European Search Report received in European Patent Application No. 14 779928.2, dated Oct. 7, 2016, n 6 pages.
Grech ED. Percutaneous coronary Intervention I: History and development. BMJ. 2003;326: 1080.
Hsu et al. ,“Review of Recent Patents on Foldable Ventricular Assist Devices,” Recent Patents on Biomedical Engineering, 2012, pp. 208-222, vol. 5.
Ide, Hirofumi et al., Evaluation of the Pulsatility of a New Pulsatile Left Ventricular Assist Device—the Integrated Cardioassist Catheter—in Dogs, J. of Thoracic and Cardiovascular Surgery 107(2): 569-0575; Feb. 1994.
Ide, Hirofumi et al., Hemodynamic Evaluation of a New Left Ventricular Assist Device, Artificial Organs 16 (3): 286-290; 1992.
International Preliminary Examination Report from the European Patent Office received in PCT Application No. PCT/US2003/04401, dated May 18, 2004, 4 pages.
International Preliminary Examination Report from the European Patent Office received in PCT Application No. PCT/US2003/04853, dated Jul. 26, 2004, 5 pages.
International Preliminary Report on Patentability and Written Opinion of the International Searching Authority received in PCT Application No. PCT/US2005/033416, dated Mar. 20, 2007, 7 pages.
International Preliminary Report on Patentability of the International Searching Authority received in PCT Application No. PCT/US2007/007313, dated Sep. 23, 2008, 6 pages.
International Search Report and Written Opinion received in International Patent Application No. PCT/US2013/040798, dated Aug. 21, 2013, in 16 pages.
International Search Report and Written Opinion received in International Patent Application No. PCT/US2013/040799, dated Aug. 21, 2013, in 19 pages.
International Search Report and Written Opinion received in International Patent Application No. PCT/US2013/040809, dated Sep. 2, 2013, in 25 pages.
International Search Report and Written Opinion received in International Patent Application No. PCT/US2013/048332, dated Oct. 16, 2013, in 17 pages.
International Search Report and Written Opinion received in International Patent Application No. PCT/US2013/048343, dated Oct. 11, 2013, in 15 pages.
International Search Report and Written Opinion received in International Patent Application No. PCT/US2016/014371, dated May 2, 2016, in 18 pages.
International Search Report and Written Opinion received in International Patent Application No. PCT/US2016/014379, dated Jul. 25, 2016, in 19 pages.
International Search Report and Written Opinion received in International Patent Application No. PCT/US2016/014391, dated May 2, 2016, in 17 pages.
International Search Report and Written Opinion received in PCT Application No. PCT/US2005/33416, dated Dec. 11, 2006, 8 pages.
International Search Report and Written Opinion received in PCT Application No. PCT/US2007/07313, dated Mar. 4, 2008, 6 pages.
International Search Report and Written Opinion received in PCT Application No. PCT/US2010/040847 dated Dec. 14, 2010, 17 pages.
International Search Report and Written Opinion received in PCT Application No. PCT/US2012/020369 dated Jul. 30, 2012.
International Search Report and Written Opinion received in PCT Application No. PCT/US2012/020382, dated Jul. 31, 2013.
International Search Report and Written Opinion received in PCT Application No. PCT/US2012/020383 dated Aug. 17, 2012.
International Search Report and Written Opinion received in PCT Application No. PCT/US2012/020553 dated Aug. 17, 2012.
International Search Report received in PCT Application No. PCT/US2003/04401, dated Nov. 10, 2003, 9 pages.
International Search Report received in PCT Application No. PCT/US2003/04853, dated Jul. 3, 2003, 3 pages.
Krishnamani R, DeNofrio D, Konstam MA Emerging ventricular assist devices for long-term cardiac support. Nat Rev Cardiol 2010; 7-71-6.
Mihaylov, D. et al., Evaluation of the Optimal Driving Mode During Left Ventricular Assist with Pulsatile Catheter Pump in Calves, Artificial Organs 23(12): 1117-1122; 1999.
Mihaylov, Di Miter et al., Development of a New Introduction Technique for the Pulsatile Catheter Pump, Artificial Organs 21 (5): 425-427; 1997.
Morgan NB. “Medical Shape memory alloy applications-the market and its products,” Mat Sci Eng 2004; 378: 16-23.
Morsink, PLJ et al., Numerical Modelling of Blood Flow Behaviour in the Valved Catheter of the PUCA Pump, a LVAD, The International Journal of Artificial Organs 20(5): 277-284; 1997.
Nishimura et al. The enabler cannula pump: a novel circulatory support system. The International Journal of Artificial Organs, vol. 22, No. 5, 1999, pp. 317-323.
Petrini L, Migliavacca F. Biomedical Applications of Shape Memory Alloys. Journal of Metallurgy 2011.
Raess D, Weber D. Impella 2.5 J. Cardiovasc Transl Res 2009; 2 (2): 168-72.
Rakhorst Gerhard et al. In Vitro Evaluation of the Influence of Pulsatile Intraventricular Pumping on Ventricular Pressure Patterns, Artificial Organs 18(7): 494-499; 1994.
Reitan, Oyvind, et al., Hemodynamic Effects of a New Percutaneous Circulatory Support Device in a Left Ventricular Failure Model. ASAIO Journal 2003: 49:731-6.
Reitan, Oyvind, et al., Hydrodynamic Properties of a New Percutaneous Intra-aortic Axial Flow Pump. ASAIO Journal 2000. pp. 323-329.
Schmitz-Rode et al., “Axial flow catheter pump for circulatory support,” Biomedizinische Technik, 2002, Band 4 7, Erganzungsband 1, Teil 1, pp. 142-143.
Schmitz-Rode, Thomas et al., “An Expandable Percutaneous Catheter Pump for Left Ventricular Support”, Journal of the American College of Cardiology, vol. 45, No. 11, 2005, pp. 1856-1861.
Shabari et al.,“Improved Hemodynamics with a Novel Miniaturized Intra-Aortic Axial Flow Pump in a Porcine Model of Acute Left Ventricular Dysfunction,” ASAIO Journal, 2013, pp. 240-245: vol. 59.
Sharony et al. Cardiopulmonary Support and Physiology—The Intra-Aortic Cannula Pump: A Novel Assist Device for the Acutely Failing Heart. The Journal of Thoracic and Cardiovascular Surgery, Nov. 1992, vol. 118, No. 5, pp. 924-929.
Written Opinion received in PCT Application No. PCT/US2003/04853, dated Feb. 25, 2004, 5 pages.
Siess et al., “Hydraulic refinement of an intraarterial microaxial blood pump”, The International Journal of Artificial Organs, 1995, vol. 18, No. 5, pp. 273-285.
Siess et al., “Concept, realization, and first in vitro testing of an intraarterial microaxial blood pump,” Artificial Organs, 1995, pp. 644-652, vol. 19, No. 7, Blackwell Science, Inc., Boston, International Society for Artificial Organs.
Siess, “Systemanalyse und Entwicklung intravasaler Rotationspumpen zur Herzunterstlitzung”, Helmholtz-Institut fur Blomedixinische Technik an der RWfH Aachen, Jun. 24, 1998, in 105 pages.
Smith EJ, et al. “First-In-Man Study of the Reitan Catheter Pump for circulatory Support in Patients Undergoing High-Risk Percutaneous Coronary Intervention,” Catheter Cardiovasc Interv 2009; 73(7):859-65.
Sokolowski W., Metcalfe A, Hayashi S., Yuahia L., Raymond k ,“Medical Applications of Shape Memory Polymers.” Biomed Mater 2007;2(1 ):S23-S27.
Stoeckel D, Pelton A, Duerig T. Self-Expanding nitinol stents: material and design considerations European Radiology. 2004; 14:292-301.
Supplemental European Search Report received from the European Patent Office in EP Application No. EP 05799883 dated Mar. 19, 2010, 3 pages.
Takagaki et al. A Novel Miniature Ventricular Assist Device for Hemodynamic Support. ASAIO Journal 2001, pp. 412-416.
Throckmorton A, et al. ,“Flexible Impeller Blades in an Axial Flow Pump for Intravascular Cavopulmonary Assistance of the Fontan Physiology.” Cardiovasc Eng Technology 2010; 1(4): 244-55.
Throckmorton et al., “Uniquely shaped cardiovascular stents enhance the pressure generation of intravascular blood pumps,” The Journal of Thoracic and Cardiovascular Surgery, Sep. 2012, pp. 704-709, vol. 133, No. 3.
Verkerke, Bart et al., The PUCA Pump: A Left Ventricular Assist Device, Artificial Organs 17(5): 365-368; 1993.
Verkerke, CJ et al., Numerical Simulation of the PUCA Pump, A Left Ventricular Assist Device, Abstracts of the XIXth ESAO Congress, The International Journal of Artificial Organs 15(9): 543; 1992.
Verkerke, Gijsbertus et al., Numerical Simulation of the Pulsating Catheter Pump: A Left Ventricular Assist Device, Artificial Organs 23(10): 924-931; 1999.
Wampler, Richard. K., et al., The Sternotomy Hemopump, A Second Generation Intraarterial Ventricular Assist Device; Johnson and Johnson Interventional Systems, pp. M218-M223 1993.
Weber et al. , “Principles of Impella Cardiac Support,” Supplemental to Cardiac Interventions Today, Aug./Sep. 2009.
Partial EP search report, dated Dec. 1, 2020, for related EP patent application No. 20187258.7 (12 pgs.).
Related Publications (1)
Number Date Country
20210077682 A1 Mar 2021 US
Provisional Applications (1)
Number Date Country
61667869 Jul 2012 US
Continuations (3)
Number Date Country
Parent 16742129 Jan 2020 US
Child 17107469 US
Parent 15242024 Aug 2016 US
Child 16742129 US
Parent 13802468 Mar 2013 US
Child 15242024 US